日本癌治療学会誌 = The journal of Japan Society of Clinical Oncology  20(2)

日本癌治療学会

国立国会図書館雑誌記事索引 1 (1) 1966.03~;本タイトル等は最新号による;刊行頻度の変更あり;並列タイトル変遷: The journal of Japan Society for Cancer Therapy (1巻1号-32巻5号)→ The journal of Japan Society of Clinical Oncology (36巻1号-);46巻1号から46巻3号には「日本癌治療学会学術集会」49回の表示もあり;34巻から41巻まで各巻1号は「日本癌治療学会学術集会プログラム号」, 各巻2号は「日本癌治療学会学術集会抄録号」として2分冊刊行. 42巻から46巻まで各巻1号は「日本癌治療学会学術集会プログラム号」, 各巻2号は「日本癌治療学会学術集会抄録号」, 各巻3号は「日本癌治療学会学術集会educational book」として3分冊刊行. 47巻以降各巻1号は「日本癌治療学会学術集会プログラム号」, 各巻2号は「日本癌治療学会学術集会educational book」として2分冊刊行;1巻1号 (Mar. 1, 1966)-;47巻3号は「JSCO」[電子資料] (USBメモリ) 50回として刊行, 48巻3号, 49巻3号は 「日本癌治療学会学術集会抄録号」 [電子資料] (USBメモリ) 51回, 52回として刊行

「国立国会図書館デジタルコレクション(雑誌)」より

[目次]

  • Presidential Lecture Recent Progress in Therapy of Urological Malignancies / T.Niijima / p185~185
  • Invitational Lecture 1. Chemotherapy of Disseminated Testicular Cancer / L.H.Einhorn / p186~187
  • Invitational Lecture 2. Stanford Achievements in Linear Accelerator Radiotherapy / M.A.Bagshaw / p188~189
  • Special Lecture 1. Experimental Approach to Bladder Cancer Based on Its Clinical Features / T.Kakizoe / p190~190
  • Special Lecture 2. MRI(Magnetic Rosonance Imaging)for the Diagnosis and Treatment of Cancers / M.Iio / p191~191
  • Special Lecture 3. Intensive Immunotherapy for Cancer / K.Orita / p192~192
  • Symposium 1 Surgical Treatment for Metastatic Tumor / / p193~199
  • 1. Retroperitoneal Lymph Node Dissection on Testis Tumors / T.Kawai et al. / p193~193
  • 2. Surgical Indication for Metastatic Liver Tumor / Y.Hata et al. / p194~194
  • 3. Surgical Treatment for Liver Metastasis from Clolrectal Cancer / S.Akimoto et al. / p195~195
  • 4. Surgical Treatment for Metastatic Lung Tumor / N.Miyazawa et al. / p196~196
  • 5. Operative Method against Metastatic Pulmonary Tumor in terms of Secondary Metastasis to the Pulmonary Draining Lymph Nodes / K.Nakagawa et al. / p197~197
  • 6.Surgical Treatment of Metastatic Bone Tumors / M.Mizutani et al. / p198~198
  • 7. Advantages of Surgical Intervention for Metastatic Brain Tumor from Lung Cancer / K.Nomura et al. / p199~199
  • Symposium 2 Virus and Human Malignancies / / p200~204
  • 1. Not Received / /
  • 2. Viral Oncogenesis of Cervical Cancer / T.kawana / p200~200
  • 3. Hepatitis B Virus(HBV)and Primary Hepatocellular Carcinoma(PHC) / K.Nishioka / p201~201
  • 4. Adult T-Cell Leukemia / S.Shirakawa / p202~202
  • 5. EB Virus and Human Malignancies / T.Osato / p203~203
  • 6. Oncogenes in Human Malignancies / M.Shibuya / p204~204
  • Symposium 3 Present Status of Multidisciplinary Treatment for Cancer / / p205~221
  • Present Status of Muleidisciplinary Therapy of Acute Leukemia / T.Masaoka / p205~206
  • 2. The Role of Combined Modality Therapy in the Management of Malignant Lymphomas / T.Oyama / p206~207
  • 3. Current Status of Combined Modalities of Therapy for Childhood Cancers / T.Ise / p207~207
  • 4. Present Status.of Multidisciplinary Treatment for Advanced Testicular Tumors / T.Kotake et al. / p208~208
  • 5. Treatment of Ovarian Cancer / M.Yakushiji / p209~209
  • 6. Multidisciplinary Treatment for Head and Neck Cancer / Y.Inuyama / p210~210
  • 7. Modern Trend in Multidisciplinary Treatment for Bone and Soft Tissue Sarcomas / K.Furuya et al. / p211~211
  • 8. The Present Status of Multidisciplinary Treatment on Malignant Melanoma / K.Ishihara / p212~212
  • 9. Multidisciplinary Treatment for Carcinoma of the Esophagus / K.Sugimachi / p213~213
  • 10. Combined Modality for Therapy of Gastric Cancer / T.Takahashi / p214~214
  • 11. Multimodality Therapy for Colorectal Cancer / S.Fujimoto et al. / p215~215
  • 12. Experimental and Clinical Study of Reduction Surgery Combined with Chemotherapy for Primary Liver Cancer / Y.Nakanishi et al. / p216~216
  • 13. Multidisciplinary Treatment for Cancer of the Pancreas / T.Suzuki et al. / p217~217
  • 14. Multidisciplinary Treatment for Lung Cancer / M.Ohta et al. / p218~218
  • 15. The Combination Chemo-endocrine Therapy for Advanced Breast Cancer / Y.Nomura et al. / p219~219
  • 16. Multidisciplinary Treatment for Choriocarcinoma / Y.Tomoda et al. / p220~220
  • 17. Multidisciplinary Treatment of Cancer of the Kidney,Bladder and Prostate / Y.Matsumura / p221~221
  • Symposium 4 Malignant Tumors of Nervous System / / p222~230
  • 1. Epidemiology of Brain Tumors / S.Manaka et al. / p222~222
  • 2. Viral Neurooncogenicity / K.Nagashima et al. / p223~223
  • 3. A New Diagnostic Method:Positron Emission Computed Tomography / K.Torizuka / p224~224
  • 4. Magnetic Resonance CT of Tumors of the Central Nervous System / T.Machida et al. / p225~225
  • 5. Treatment of Neuroblastoma / T.Sawada et al. / p226~226
  • 6. Diagnosis and Surgical Therapy of Neuroblastoma / J.Yokohama et al. / p227~227
  • 7. Photochemotherapy in Retinoblastoma / Y.Ohnishi / p228~228
  • 8. Radiation Therapy for Glioblastoma Multiforme / M.Matsutani / p229~229
  • 9. Chemotherapy of Malignant Gliomas / Y.Ushio et al. / p230~230
  • Symposium 5 Terminal Care for Cancer Patients / / p231~237
  • 1. The Management of Advanced Cancer Pain / T.Mizuguchi / p231~231
  • 2. Urinary Diversion and Intestinal Operation in Terminal Stage Cancer of Uterine Cervix Patients / K.Ohmi / p232~232
  • 3. Care for Children with Terminal Cancers and Approach to Their Families / M.Sakurai / p233~233
  • 4. Terminal Care of Cancer Patients from a Standpoint of Therapeutic Concerns of Anesthesiologist / Y.Yoshida / p234~234
  • 5. Care for the Terminal Cancer Patients:The Responsibility of Preventive Medicine / S.Yamamoto / p235~235
  • 6. Terminal Care for Cancer Patients at the Seirei Hospice / S.Chihara et al. / p236~236
  • 7. Terminal Care of Cancer Patients,with Special Emphasis on the Aged and External Opening of Urinary Tract / T.Nagayama / p237~237
  • Panel Discussion 1 Clinical Application of Non-specific Immuno-potentiators / / p238~241
  • 1. Adjuvant Immunotherapy by N-CWS for Head-and-neck Malignancies / S.Sakai / p238~238
  • 2. Randomized Protocol Study for BCG Immunotherapy as an Adjuvant to Surgery in Lung Cancer / R.Tsuchiya et al. / p238~238
  • 3. Effects of Immunotherapy Using the Non-specific Immunopotentiator,OK-432 for Malignant Ovarian Tumors / M.Ohta et al. / p238~238
  • 4. Evaluation on Application of Nonspecific Immuno-potentiators to Urogenital Cancer Patients / Y.Nakagami et al. / p239~239
  • 5. A Controlled Study of Surgical Adjuvant Chemoimmunotherapy with FT-207 and OK-432 for Advanced Stomach Cancer / Y.Yamamura et al. / p239~239
  • 6. Postoperative Alternating Administration of Carbazilquinone and PSK for Gastrointestinal Cancers / H.Ichihashi et al. / p239~239
  • 7. Clinical Efficacy of Lentinan,an Immuno Potentiating Agent,in the Patients with Advanced Gastric, Colorectal and Breast Cancer / M.Akimoto et al. / p240~240
  • 8. Chemo-Immunotherapy for Advanced Gastric Cancer / Y.Kato et al. / p240~240
  • 9. Preoperative Immunochemotherapy for Gastric Cancer Combined with Perifocal Administration of KO-432 / M.Mukai et al. / p240~240
  • 10. The Difference in the Clinical Evaluation of Non-specific Immunostimulator and Biological Response Modifiers / N.Saijo et al. / p241~241
  • Panel Discussion 2 Present Status of Tumor Markers / / p242~246
  • 1. Comparison of New Markers for Diagnosis of Pancreatic Carcinoma:CA19/9,CA125 and DuPan-2 / H.Ohkura et al. / p242~242
  • 2. The Present Condition of Tumor Marker in Malignant Ovarian Tumor / H.Nishimura / p242~242
  • 3. Clinical Value of SCC-Antigen,a Subfraction of Tumor Antigen TA-4,for the Management of Cervical Cancer / H.Kato et al. / p242~242
  • 4. Clinical Investigation of Basic Fetoprotein(BFP)and Carcinoembryonic Antigen(CEA)in Stomach Cancer and Lung Cancer / Y.Kanda et al. / p243~243
  • 5. An Evaluation of Prostate Antigen(PA)in Prostate Cancer / M.Kuriyama / p243~243
  • 6. Alpha-fetoprotein Subfractions in Hepatic Cancer or Germ Cell Tumor Identified by the High Sensitive Lectin Affinity Crossed-line Immunoelectrophoresis / T.Ishiguro et al. / p243~243
  • 7. Tumor Markers:Clinical Significance of CEA Levels in Lung Cancer / N.Hara et al. / p244~244
  • 8. Clinical Evaluation of CA 19-9,TPA,IAP&5'-NPD-V as Tumor Marker in Hepatocellular Carcinoma, Bile Duct Carcinoma&Pancreas Carcinoma / H.Takahashi et al. / p244~244
  • 9. Measurement of Serum Pancreatic Oncofetal Antigen(POA)and Carbohydrate Antigen 19-9(CA 19-9)Levels in Patients with Pancreatic Cancers / H.Takami et al. / p244~244
  • 10. Clinical Utility of Tumor Markers in Gastric and Colon Cancer / K.Ogawa et al. / p245~245
  • 11. Clinical Evaluation of CEA in Colorectal Carcinoma / T.Shimoyama et al. / p245~245
  • 12. Studies on CA 125,CA 19-9,TPA and LAP as Tumor Markers in Patients with Ovarian Cancer / Y.Negishi et al. / p245~245
  • 13. The Clinical Evaluation of Serum PAP and PA in the Prostatic Cancer / M.Miki / p246~246
  • Panel Discussion 3 Embolization in Cancer Therapy / / p247~250
  • 1. Transcatheter Hepatic Arterial Embolization of 423 Patients with Hepatoma / M.Sato et al. / p247~247
  • 2. The Effect of TAE on Primary Hepatoma--Its Relation to Portogram / K.Honda et al. / p247~247
  • 3. Arterial Chemoembolization with Mitomycin C Microcapsules and in Combination with Gelfoam in the Treatment of Hepatocellular Carcinoma / K.Ohnishi et al. / p247~247
  • 4. Effective Embolization for Hepatic Surgery / H.Mutou et al. / p248~248
  • 5. Hepatic Artery Embolization in the Treatment of Metastatic Liver Tumors / K.Ido et al. / p248~248
  • 6. Transcatheter Embolization of Renal Cancer / H.Nakano / p248~248
  • 7. The Role of Preoperative Embolization in Renal Cell Carcinoma / F.Masuda / p249~249
  • 8. Chemoembolization of Genitourinary Cancers with Microencapsulated Anticancer Drug / Y.Tamakawa et al. / p249~249
  • 9. Targeting Chemoembolization for Malignant Solid Tumors by Arterial Administration of Anticancer Agent Dissolved in Lipiodol / T.Konno et al. / p249~249
  • 10. As the New Approach to Transcatheter Arterial Embolization:Absolute Ethanol and Radioactive Lipiodol (I-131 Lip.) / H.Kobayashi et al. / p250~250
  • 11. Drug Slow-releasing Properties and Antitumor Effect of Anticancer Drug-encapsulated Silicone Elastomer for Use in Chemoembolization Therapy / Y.Mizutani et al. / p250~250
  • Panel Discussion 4 Present Condition of Application of Monoclonal Antibodies / / p251~255
  • I. Therapy with Monoclonal Antibodies 1. "Missile Therapy",by Using the Conjugates of Anticancer Drugs with Monoclonal Antibody against Human Colon Cancers / H.Kotanagi et al. / p251~251
  • I. Therapy with Monoclonal Antibodies 2. Targeting Chemotherapy Using Adriamycin Entrapped in Liposomes Conjugated with Monoclonal Antibody / K.Kumai et al. / p251~251
  • I. Therapy with Monoclonal Antibodies 3. Total Therapy of Adult Acute Lymphoblastic Leukemia(ALL)by Chemotherapy and Transplantation of Monoclonal Antibodies-treated Autologous Bone Marrow Cells / R.Ohno et al. / p251~251
  • II. Imaging with Monoclonal Antibodies 4. Application of the Anti-CEA Monoclonal Antibody to Tumor Positive Scanning / Y.Hata et al. / p252~252
  • II. Imaging with Monoclonal Antibodies 5. Radioimmunodetection of Human Gastric Cancer in Athymic Mice by Mono-clonal Antibody / T. Watanabe et al. / p252~252
  • II. Imaging with Monoclonal Antibodies 6. Radioimmunodetection of Tumors Using Monoclonal Antibodies Labeled with Metallic Radionuclides / K.Endo et al. / p252~252
  • III. Development of New Monoclonal Antibodies 7. The Reactivity of Monoclonal Antibodies against Human Bladder Cancer / S.Kagawa et al. / p253~253
  • III. Development of New Monoclonal Antibodies 8. Reactivity of Monoclonal Antibodies to Human Urinary Bladder Cancers / I. Numata et al. / p253~253
  • III. Development of New Monoclonal Antibodies 9. The Analysis of Monoclonal Antibodies to Bladder Cancer Cells / M.Kawashima et al. / p253~253
  • III. Development of New Monoclonal Antibodies 10. Analysis of the Tumor Antigens and Clinical Application of Neuroblastoma Using Monoclonal Anti-neuroblastoma Antibodies / T.Etoh et al. / p254~254
  • IV. Subsets of Lymphocyte 11. Changes of Subsets of Lymphocytes in the Peripheral Blood and Infiltrating in the Cancer Tissue during the Radiotherapy--Analysis with Monoclonal Antibody / F.Hamada et al. / p254~254
  • IV. Subsets of Lymphocyte 12. Immunohistochemical Analysis of Spleen in Advanced Gastric Cancer / S.Hiramatsu et al. / p254~254
  • IV. Subsets of Lymphocyte 13. Distribution of T Cell Subsets and ADCC in Peripheral Blood Lymphocytes and Regional Lymphnode in Patients with Stomach Cancer / K.Nishiyama et al. / p255~255
  • Panel Discussion 5 Rehabilitation in Cancer Therapy--Adult Cancer and Pediatric Cancer / / p256~258
  • 1. Reconstruction Following Surgery for Cancer of the Oral Cavity and Pharynx / S.Ebihara et al. / p256~256
  • 2. Conservative Treatment of Retinoblastoma and Reconstruction of Visual Function / K.Minoda / p256~256
  • 3. Rehabilitation with Maxillofacial Prosthetics / K.Seto / p256~256
  • 4. Reconstructive Surgery after Mastectomy
  • Some Evaluation with Psychological Survey / M.Anze / p257~257
  • 5. Functional Evaluation after Radical Operation and Reconstruction for Malignant Bone Tumor Cases in the Extremities / A.Tateishi et al. / p257~257
  • 6. Rehabilitation after Anti-cancerous Procedures against Malignant Tumors of Urogeni-tal Organs / K.Ohtaguro / p257~257
  • 7. Radiation Injury after Radiation Therapy and Treatment / A.Yamada et al. / p258~258
  • Panel Discussion 6 Analysis of Survival Rate and Survival Time of Cancer Patient / / p259~264
  • I. Introduction and Practice in Analysis 1. Gap between Statistical Theory and Practice in Analysis of Follow-up Data of Cancer Patients / S.Maetani et al. / p259~259
  • I. Introduction and Practice in Analysis 2. The Survival Rates for Curatively Resected Patients with Stomach Cancer / J.Fujimoto et al. / p259~259
  • I. Introduction and Practice in Analysis 3. Prognostic Implications of Stage and Metastatic Sites in Patients with Small Cell Lung Carcinoma (SCLC) / H.Niitani'et al. / p259~259
  • I. Introduction and Practice in Analysis 4. An Investigation of Survival Rate for 5451 Uterine Cervical Cancer Cases at Dept.of Gynecology,Cancer Institute Hospital / T.Musha et al. / p260~260
  • I. Introduction and Practice in Analysis 5. Analyses of Prognostic Factors in Acute Lymphocytic Leukemia in Children / Y.Hiyoshi et al. / p260~260
  • II. Management of Data 6. Methodology of Survival Time Studies / H.Nakazato / p260~260
  • II. Management of Data 7. Problems on Calculation of Survival Rate from Data and Informations of Registrat-ed Cancer Patients Collecting from 200 Hospitals in Japan to Information Center of National Cancer Center Hospital / O.Takatani et al. / p261~261
  • III. Methods of Analysis 8. Not Received / /
  • III. Methods of Analysis 9. Analysis of Methods of Estimation for Survival Rate in Adults Acute Non-Lymphocytic Leukemia (Adults ANLL) / E.Nagura et al. / p261~261
  • III. Methods of Analysis 10. Analysis of Survival Rates of the Patients with Recurrent Breast Cancer by Cox-Mantel Method,Logrank Method,Generalized Wilcoxon Method and Cox's Hazard Model / T.Tsukui et al. / p261~261
  • III. Methods of Analysis 11. Application of Analysis of Variance to Analysis of Survival-Time Data / T.Tamiya et al. / p262~262
  • III. Methods of Analysis 12. Role of Survival Rate in Metastatic Brain Tumors / H.Yamamoto et al. / p262~262
  • III. Methods of Analysis 13. Relative Survival Rate after Curative Surgery for Gastric Cancer / S.Hirose et al. / p262~262
  • IV. Background Factors 14. Withdrawals and Background Factor Deviations in Clinical Randomized Controlled Trial / K.Kumai et al. / p263~263
  • IV. Background Factors 15. Problems in Historical Control in Clinical Study and Data-based Correction of Bias / T.Nakajima / p263~263
  • IV. Background Factors 16. Study on the Prognosis of Breast Cancer Patients after Radical Mastectomy,Using Multivariate Analysis / T.Ikeda et al. / p263~263
  • V. Theories 17. Multiple Comparison in Statistical Test and Standard Error at 0% or 100% Sample Proportion / T.Onoda et al. / p264~264
  • V. Theories 18. Sensitivity of Statistical Inference--Use of Background Factors / A.Sakuma / p264~264
  • Panel Discussion 7 Cancer Therapy with Medical Electronics (ME) / / p265~268
  • I. Therapy with Laser 1. CO₂ Laser in Treating Head and Neck Cancer / M.Hirano / p265~265
  • I. Therapy with Laser 2. Treatment of Neoplasms of the Uterine Cervix by CO₂ Laser / S.Sekimoto / p265~265
  • I. Therapy with Laser 3. Transurethral Laser Surgery for Bladder Tumor / K.Okada et al. / p265~265
  • I. Therapy with Laser 4. Laser Treatment--Photodynamic Therapy for Cancer / H.Kato et al. / p266~266
  • I. Therapy with Laser 5. Whole Bladder Wall Photodynamic Therapy for CIS and Superficial Tumors of the Bladder / H.Hisazumi et al. / p266~266
  • II. Therapy with Hyperthermia 6. Hyperthermia / S.Egawa et al. / p266~266
  • II. Therapy with Hyperthermia 7. Hyperthermia :Microwave Hyperthermia in Combination with Intra-arterial Infusion Chemother-apy for Cancer of the Head of Pancreas / T.Miura et al. / p267~267
  • III. Therapy with Cryosurgery 8. Cryosurgery (in General Surgery and in the Borderline Fields) / S.Tanaka / p267~267
  • III. Therapy with Cryosurgery 9. Cryoprostatectomy on Prostatic Gland Tumors / Y.Hikichi / p267~267
  • IV. Therapy with Ultrasonics 10. Not Received / /
  • IV. Therapy with Ultrasonics 11. Cavitron Ultrasonic Surgical Aspirator(CUSA)System Gastroenterological and Hepatic Surgery / N.Kawano et al. / p268~268
  • V. Anesthesia with Electric Stimulation 12. Managenent of Cancer Pain with Epidural Spinal Cord Stimulation / K.Shimoji et al. / p268~268
  • Panel Discussion 8 Clinical Application of Newly Developed Anti-cancer Agents / / p269~271
  • 1. 590-S / H.Furue et al. / p269~269
  • 2. Evaluation of Clinical Effect of 5'-Deoxy-5-Fluorouridine / Y.Nakano et al. / p269~269
  • 3. Chemotherapy of Gastric Cancer--UFT,UFTM,UFTM-Dpc Treatment / S.Suga et al. / p269~269
  • 4. Phase H Study of PL-AC on Acute Leukemia / K.Yamada / p270~270
  • 5. SM-108 / Y.Uzuka et al. / p270~270
  • 6. Mitoxantrone / I.Kimura / p270~270
  • 7. Clinical Study of 4'-O-Tetra-Hydropyranyl Doxorubicin (THP-ADM) / H.Majima / p271~271
  • 8. Clinical Evaluation of 4'-epi-adriamycin / H.Shibata et al. / p271~271
  • 9. Phase II-III Trials of VP16-213 / M.Ogawa / p271~271
  • Panel Discussion 9 Hormone Therapy for Cancer / / p272~273
  • 1. Hormone Therapy for Breast Cancer--Its Role in the Treatment of Breast Cancer / H.Koyama / p272~272
  • 2. Hormonal Therapy of Endometrial Cancer / J.Kato / p272~272
  • 3. Chemo-endocrine Therapy for Diffuse Carcinoma of the Stomach and Its Clinical Evaluation / H.Kitaoka / p272~272
  • 4. Prostatic Cancer / J.shimazaki / p273~273
  • 5. The Role of Adrenal Steroid Hormone in Cancer Therapy / N.Ohsawa / p273~273
  • Panel Discussion 10 Side Effects in Cancer Therapy and Countermeasure--Mainly Concerning Infection and Multi-organ Failure / / p274~276
  • 1. Clinical Features and Role of Postoperative Infections in Cancer of Digestive Organs / K.Ishibiki et al. / p274~274
  • 2. Infectious Complications Emerged in the Course of Treatment of Lung Cancer / K.Oizumi / p274~274
  • 3. Infectious Complications and Infection Prevention in Patients with Acute Leukemia / H.Teshima et al. / p274~274
  • 4. Infectious Diseases at the Treatment of Urinary Tract and Genital Organ Tumors / J.Kumazawa / p275~275
  • 5. Organ Disturbances by Urogenital Cancer Chemotherapy and Their Prevention / K.Suzuki et a1. / p275~275
  • 6. Suppression of CDDP Induced Renal Toxicity by Sodium Selenite / M.Yokoyama et al. / p275~275
  • 7. Radiation Therapy-Induced Organ Injuries and Measures against Them / S.Yanagawa et al. / p276~276
  • 8. Organ Dysfunctions Caused by Cancer Therapy in Children / F.Bessho et al. / p276~276
  • Panel Discussion 11 Clinical Application of Interferon / / p277~280
  • 1. Efficacy of HLBI for Renal Cell Cancer / K.Ota / p277~277
  • 2. Clinical Studies of Interferon Treatment on Patients with Various Malignant Tumors / H.Mugitani / p277~277
  • 3. Experimental Studies on Combined Usage of Interferon and Various Anticancer Agents against Human Tumor Xenografts Transplanted in Nude Mice / Y.Nosoh et al. / p277~277
  • 4. Clinical Studies of Recombinant Leukocyte A Interferon (γ-IFN-αA,Ro22-8181) / T.Taguchi / p278~278
  • 5. Clinical Evaluation of Interferon on Malignant Bone and Soft Tissue Tumors of the Extremities / S.Toriyama et al / p278~278
  • 6. Clinical Evaluation of Interferon Therapy for Malignant Brain Tumors / M.Nagai et al. / p278~278
  • 7. The Treatment of Renal Cell Carcinoma with Recombinant Human Leukocyte Interferon / J.Kawamura / p279~279
  • 8. Application of Interferon in the Treatment of Malignant Tumors of the Skin / A.Yamamoto et al. / p279~279
  • 9. Combination Therapies of Interferons / J.Imanishi et al. / p279~279
  • 10. Antitumor Mechanisms of Murine IFN-γ / T.Ebina / p280~280
  • General Lecture 1. Flow Cytometric Analysis of Cellular Transport of Adriamycin / K.Sasaki et al. / p281~281
  • General Lecture 2. Pharmacokinetics of Cisplatin in vitro & in vivo / T.Ishibashi et al. / p281~281
  • General Lecture 3. Pharmacological Study of Cis-diamminedichloroplatinum(II)(CDDP)in Patients with Ovarian Carcinoma / S.Kodama et al. / p281~281
  • General Lecture 4. Biliary and Pancreatic Excretion of Mitomycin C,with Special Reference to the Concomitant Use of Urokinase / Y.Suda et al. / p282~282
  • General Lecture 5. Serum and Urine Concentrations of BLM(Bleomycin)Following Administration into the Vagina of Cases with Uterine Cervical Cancer / K.Sato et a1. / p282~282
  • General Lecture 6. Preoperative Chemotherapy against Colon Cancer--Pharmacokinetics and Metabolism of HCFU / S.Owada et al. / p282~282
  • General Lecture 7. DNA and RNA Content of the Various Human Tumor Cell Lines and Cell Kinetic Charges toward the Anticancer Drugs / Y.Tagawa et al. / p283~283
  • General Lecture 8. Experimental Pulmonary Transplantation of Human Osteosarcoma Cells in Nude Mice and Effects of Experimental Chemotherapy / T.Yagi et al. / p283~283
  • General Lecture 9. The Effect of the Metabolic Agent on the Anticancerous Agent in the Different Nutritional Support / H.Nagano et al. / p283~283
  • General Lecture 10. Combined Cytotoxic Effect of Two Antimetabolites of 9L Rat Brain Tumor Cells / S.Kobayashi et a1. / p284~284
  • General Lecture 11. Targetting Chemotherapy for the Metastatic Lymph Nodes of Breast Cancer with Mitomycin C Adsorbed to Small Sized Activated Carbon Particle / K.Fujii et a1. / p284~284
  • General Lecture 12. Systemic Chemotherapy of Mammary Carcinoma / Y.Murayama et al. / p284~284
  • General Lecture 13. Cisplatin Trials in Treatment of Ovarian Cancer / S.Izumi et al. / p285~285
  • General Lecture 14. CDDP-ACR-CPA Combination Chemotherapy for Malignant Ovarian Tumors / N.Ushiki et al. / p285~285
  • General Lecture 15. Clinical Evaluation of FCAP(5-Fu,Cyclophosphamide,Adriamycin,Cisplatin)in Ovarian Cancer / H.Yuzawa et al. / p285~285
  • General Lecture 16. The Effect of Combined Chemotherapy(CAP)on Gynecological Malignant Disorders / O.Iwanari et al. / p286~286
  • General Lecture 17. Intraperitoneal(IP)Cisplatinum(CDDP)Chemotherapy in Patients with Ovarian Cancer / T.Noda et al. / p286~286
  • General Lecture 18. Study on Recurrent Chorionic Diseases / N.Komuro et al. / p286~286
  • General Lecture 19. Bleomycin Concentration and Histologic Findings in the Tissue of the Patients with Esophageal Carcinoma, Medicated Orally with Oil-Bleomycin before Operation / K.Monma et al. / p287~287
  • General Lecture 20. Mode of Cytosine Arabinoside(Ara-C)Transport to Leukemia Cells / M.Uchida et al. / p287~287
  • General Lecture 21. A Study on Plasma and Tissue UFT Concentrations in Patients with Cervical Cancer / Y.Kawai et al. / p287~287
  • General Lecture 22. Pharmacokinetics of Vaginal Suppository Tegafur on Uterine Cervical Cancer and Radiation Therapy / T.Noda et al. / p288~288
  • General Lecture 23. Influence of a Cytotoxic Agent on the Tumorigenesis in LT/Sv Mouse / T.Araki et al. / p288~288
  • General Lecture 24. Study on Route of Administration of Cisplatin in Tumor-Bearing Rats / H.Iwasawa et al. / p288~288
  • General Lecture 25. The Effect of Protamine Sulfate on the Uptake of Vincristine by P-388/VCR Murine Leukemia Cells / M.Ido et al. / p289~289
  • General Lecture 26. Effects of Continuous Intravesical Instillation of Anticancer Agent on Chemical Carcinogenesis in Rats / S.Kawano et al. / p289~289
  • General Lecture 27. Combined Chemo-Radiation Therapy for Human Urogenital Malignant Tumors Transplantable to Nude Mice / J.Hasegawa et al. / p289~289
  • General Lecture 28. Combination Chemotherapy with Cis-platinum for Malignant Ovarian Tumor / T.Kubota et al. / p290~290
  • General Lecture 29. Chemotherapy of Advanced Epitherial Ovarian Cancer with Combination of Cisplatin(P),Adriamycin(A),and Cyclophosphamide(C) / R.Tsunematsu et al. / p290~290
  • General Lecture 30. A Clinical Analysis of Malignant Ovarian Germ Cell Tumors with Elevated Serum Alpha Fetoprotein / T.Nishida et al. / p290~290
  • General Lecture 31. PVB Therapy of Nonseminomatous Tumors / N.Kondo et al. / p291~291
  • General Lecture 32. PPA(CDDP,PEP,ADM)Combination Chemotherapy in the Genitourinary Carcinoma / Y.Ono et al. / p291~291
  • General Lecture 33. Combination Chemotherapy with CPDD,5-FU and PEP in Head and Neck Malignant Tumors / T.Furusaka et al. / p291~291
  • General Lecture 34. Combination Chemotherapy with Cisplatinum and Peplomycin in Head and Neck Squamous Cell Carcinoma / T.Takaoka et al. / p292~292
  • General Lecture 35. The Combination Chemotherapy with Cisplatin and 5-FU for the Head and Neck Cancer / T.Sonoda et al. / p292~292
  • General Lecture 36. Clinical Results with Cisplatinum in Advanced Oral Cancer / S.Iwamoto et al. / p292~292
  • General Lecture 37. Combination Chemotherapy for Squamous Cell Carcinoma with Vindesine, Peplomycin, and Cis-platinum (DPCp) / F.Nakanishi et al. / p293~293
  • General Lecture 38. Cisplatin Therapy for Advanced Refractory Thyroid Cancer / T.Tabei et al. / p293~293
  • General Lecture 39. Fundamental and Clinical Study on UFT / M.Kinashi et al. / p293~293
  • General Lecture 40. Effect of UFT on Peritonitis Carcinomatosa in Mice / T.Kurokawa et al. / p294~294
  • General Lecture 41. Effect of UFT on Urinary Bladder Tumors in Rats Induced by N-butyl-N-(4- hydroxybutyl) nitrosamine (BHBN) / S.Samma et al. / p294~294
  • General Lecture 42. Clinical Result of Chemotherapy of Oral UFT in Carcinoma of Head and Neck / J.Tanaka et al. / p294~294
  • General Lecture 43. Proposal of D-penicillamine Treatment for Borrmann Type 4 Gastric Cancer in Combination with UFTM-chemotherapy--A Clinical Trial of Enhancement of Anticancer Activity from the Point of View of Suppression of Connective Tissue Proliferation / K.Ina et al. / p295~295
  • General Lecture 44. Effect of UFT on Far Advanced Renal Cell Cancer / K.Koseki et al. / p295~295
  • General Lecture 45. Clinical Study of UFT for Renal Cell Carcinoma / F.Masuda et al. / p295~295
  • General Lecture 46. Efficacy and Safety of 5'-deoxy-5-fluorouridine(5'-DFUR)by Intermittent Administration / S.Taguchi et al. / p296~296
  • General Lecture 47. A Phase II Study of 5'-DFUR (5'-deoxy-5-fluorouridine) / J.Ota et al. / p296~296
  • General Lecture 48. Phase II Study of 5'-DFUR to Patients with Primary Lung Cancers and Metastatic Lung Tumors / M.Tamura et al. / p296~296
  • General Lecture 49. Clinical Use of 5'-deoxy-5-fluorouridine(5'-DFUR)on Recurrent Breast Cancer / T.Ueda et al. / p297~297
  • General Lecture 50. Antitumor Effect of 5'-DFUR(5'-deoxy-fluorouridine)on Cancer Patients / M.Kitamura et al. / p297~297
  • General Lecture 51. Phase II Trial of 5'-Deoxy-5-Fluorouridine(5-DFUR)in Advanced Colorectal Cancer / M.Yasue et al. / p297~297
  • General Lecture 52. Effect of Radiotherapy and/or MCNU on Malignant Brain Tumors / K.Harada et al. / p298~298
  • General Lecture 53. Effect of MCNU on Malignant Brain Tumors--Experimental and Clinical Study / T.Wakabayashi et al. / p298~298
  • General Lecture 54. Effect of MCNU to Hematological Malignancies / I.Tanaka et al. / p298~298
  • General Lecture 55, Correlation of Ornithine Decarboxylase Activity and Antitumor Effect of α-Difluoromethyl Ornithine(DFMO)in Human Tumors Transplanted into Nude Mice / S.Umemoto et al. / p299~299
  • General Lecture 56. Combined Therapy with Polyamine Antimetabolites and Mitomycin C / R.Shrestha et al. / p299~299
  • General Lecture 57. rCBF in Brain Tumors as Measured by Xenon Enhanced CT / O.Nakamura et al. / p299~299
  • General Lecture 58. Computed Tomographic Diagnosis of Esophageal Carcinoma / T.Fukuda et al. / p300~300
  • General Lecture 59. CT of the Liver Cancer after Administration of the SMANCS/Lpd / S.Maki et al. / p300~300
  • General Lecture 60. Early Diagnosis of Pancreatic Cancer with CT--Limitation and Signification of Picturing the Bile and Pancreatic Ducts by 10mm Thickness Slice CT Scan / Y.Furukawa et al. / p300~300
  • General Lecture 61. Significance of Computed Tomography(CT)in Diagnosis of Uterine Cervical Carcinoma / K.Sakumoto et al. / p301~301
  • General Lecture 62. CT Analysis in Endometrial Carcinoma / M.Takahashi et al. / p301~301
  • General Lecture 63. Sonographic Evaluation of the Therapeutic- Effect in the Abdominal Involvement of Malignant Lymphoma / S.Yoshimatsu et al. / p301~301
  • General Lecture 64. Ultrasonical Diagnosis of Nodular Goiter--New Diagnostic Criteria of Thyroid Cancer / A.Kawauchi et al. / p302~302
  • General Lecture 65. An Experimental Study of Ultrasonographic Diagnosis of Lymph Node Metastases of Breast Cancer / S.Nakatani et al. / p302~302
  • General Lecture 66. Not Received / /
  • General Lecture 67. Ultrasound Evaluation of Malignancy of Ovarian Tumor by Quantification Analysis / M.Nishi et al. / p302~302
  • General Lecture 68. Endoscopic Photodynamic Therapy of Stomach and Colon Tumors / Y.Ito et al. / p303~303
  • General Lecture 69. Endoscopic LASER Treatment of the Rectal Polyps after Total Colectomy in Patients with Familial Polyposis / K.Yasui et al. / p303~303
  • General Lecture 70. Laser Surgery in the Pharyngeal Malignancy / M.Miyata et al. / p303~303
  • General Lecture 71. YAG and CO₂ Laser Therapies for Cervical Neoplasm / N.Sasaki et al. / p304~304
  • General Lecture 72. Photodynamic Therapy for Penial Carcinoma / T.Misaki et al. / p304~304
  • General Lecture 73. Experimental Studies on the High-zone Tolerance after Cryosurgery and Attempts on Its Prevention by Preoperative Administration of Cyclophosphamide or OK-432 / K.Miya et al. / p304~304
  • General Lecture 74. Experimental Study of Cryochemotherapy for VX2 Carcinoma in the Liver / H.Imai et al. / p305~305
  • General Lecture 75. Experimental Studies of the Incidence of Metastasis Following the Microwave Coagulation Therapy for Malignant Tumors(2nd Report) / H.Yamaue et al. / p305~305
  • General Lecture 76. Evaluation of the Microwave Coagulation. Therapy for Carcinoma of the Gastrointes tinal Tract / Y.Nagai et al. / p305~305
  • General Lecture 77. Adjuvant Chemotherapy for Localized(Stage I,II)Non-Hodgkin's Lymphoma / Y.Kuraishi et al. / p306~306
  • General Lecture 78. Prognosis of Non-Hodgkin Lymphoma of the Nasal Cavity and Paranasal Sinuses / M.Kondo et al. / p306~306
  • General Lecture 79. Clinical Analysis on Children with Non-Hodgkin's Lymphoma / T.Shitara et al. / p306~306
  • General Lecture 80. Non-Hodgkin Lymphoma of the Waldeyer's Ring:Prognostic Factors and Role of Lymphangiography and Gallium-scan in Clinical Stage I-II Patients / N.Shigematsu et al. / p307~307
  • General Lecture 81. Full Dose CHOP Chemotherapy(CHOP): Feasibility and Treatment Result / S.Tominaga et al. / p307~307
  • General Lecture 82. Evaluation of Multi-Disciplinary Treatment Combined with Intraarterial Chemother-apy for Carcinoma of the Mesopharynx / S.Matsuura et al. / p307~307
  • General Lecture 83. Combination Therapy for Carcinoma of Lateral Wall of the Mesopharynx / W.Ohyama et al. / p308~308
  • General Lecture 84. Analysis of Treatment Modalities for Maxillary Carcinoma / H.Tsujii et al. / p308~308
  • General Lecture 85. Mulidisciplinary Treatment for Advanced Nasopharyngeal Carcinoma / H.Miyashita et al. / p308~308
  • General Lecture 86. Review of Intra-Arterial Infusion-Radiation Therapy for Nasopharynx Carcinoma / Y.Nomura et al. / p309~309
  • General Lecture 87. Treatment Costs of Patients with Head and Neck Cancer / B.Satake et al. / p309~309
  • General Lecture 88. Combination Therapy of Irradiation and CDDP on Esophageal Carcinoma / N.Tohnosu et al. / p309~309
  • General Lecture 89. Application of Cisplatin in Esophageal Cancer / S.Onoda et al. / p310~310
  • General Lecture 90. Therapeutic Principle of stage IV Gastric Cancer / Y.Tabuchi et al. / p310~310
  • General Lecture 91. Preoperative Combination Therapy of 5-fluorouracil Suppository and Irradiation for Rectal Cancer / H.Mizusawa et al. / p310~310
  • General Lecture 92. Clinical and Pathological Evaluation of Preoperative Irradiation and Anti-Cancer Drugs Injection for Rectal Cancer / H.Sarashina et al. / p311~311
  • General Lecture 93. Efficacy of Irradiation Combined with Resection in the Treatment of Cancer of Pancreaticoduodenal Region / E.Miura et al. / p311~311
  • General Lecture 94. Clinical Trial of Cytoreductive Surgery Followed by Chemo-endocrine Therapy in stage IV Breast Cancer with Poor Prognostic Features / Y.Nakamura et al. / p311~311
  • General Lecture 95. ATOK Therapy(Adriamycin,Tamoxifen and OK432)for Advanced Breast Cancer / K.Sawai et al. / p312~312
  • General Lecture 96. Chemo-endocrine Therapy for Advanced Breast Cancer (ACFT Therapy) / N.Horikoshi et al. / p312~312
  • General Lecture 97. An Analysis of Carcinoma of the Breast--The Significance of Parasternal Lymphnode Involvement / M Sowa et al. / p312~312
  • General Lecture 98. Prognosis of Resected Breast Cancer among Atomic Bomb Survivor / S.Nakao et al. / p313~313
  • General Lecture 99. Combination Chemotherapy with CDDP, Vincristine, and Peplomycin Followed by Radiation Therapy for Advanced Cervical Cancer / Y.Araki et al. / p313~313
  • General Lecture 100. Therapeutic Regimen for Endometrial Cancer / M.Mushika et al. / p313~313
  • General Lecture 101. Therapeutic Results of Endometrial Carcinoma / H.Iwasaki et al. / p314~314
  • General Lecture 102. An Attempt of Second Look Laparoscopy against Malignant Ovarian Tumor / T.Yokokawa et al. / p314~314
  • General Lecture 103. The Combination Therapy for Vaginal and Vulvar Malignancies / K.Fujiwara et al. / p314~314
  • General Lecture 104. Pregnancies after Chemotherapy of Trophoblastic Disease / O. Kobayashi et al. / p315~315
  • General Lecture 105. Multi-disciplinary Treatment for Invasive Bladder Cancer / S.Isaka et al. / p315~315
  • General Lecture 106. The Therapeutic Results of Advanced Bladder Cancer at the Department of Urology,Okayama University / T.Tsushima et al. / p315~315
  • General Lecture 107. Studies on Early Effects of Pre-operative Adjuvant Therapy for Bladder Cancer / Y.Yushita et al. / p316~316
  • General Lecture 108. Clinical Studies of Testicular Tumors Problems Encountered in the Treatment on Non-Seminoma -Part 1 / T.Sugawara et al. / p316~316
  • General Lecture 109. Long-term Survival Rate of Pediatric Malignant Diseases in Kanagawa Children's Medical Center / H.Nishihira et al. / p316~316
  • General Lecture 110, Combined Chemotherapy and Radiotherapy in Non-Small Cell Lung Cancer / S.Yoneda et al. / p317~317
  • General Lecture 111. Clinical Study of Combination Therapies for 20 Cases of Squamous Cell Carcinoma of the Skin of the Extremities / J.Manabe et al. / p317~317
  • General Lecture 112. Combined Therapy(Biliary Endoprosthesis,Hyperthermia and Radiation)for the Non-resectable Malignant Obstructive Jaundice / S.Sawada et al. / p317~317
  • General Lecture 113. Clinico-experimental Study of Radiation with ACNU for Cancer--Usefulness of Fractionated Drug Administration / T.Okawa et al. / p318~318
  • General Lecture 114. A Contrived Procedure on Proton Treatment Planning / K. Ohara et al. / p318~318
  • General Lecture 115. Use of Radiotherapy by High-Energy Protons in the Postoperative Treatment of Brain Tumor(Part 1) / Y.Yoshii et al. / p318~318
  • General Lecture 116. Clinical Trial of Proton Beam to the Treatment of the Carcinoma of Tongue / H.Fukuda et al. / p319~319
  • General Lecture 117. A Trial of Proton Beam Therapy for a Patient with Cervical Carcinoma / M.Kaneko et al. / p319~319
  • General Lecture 118. A Trial of Proton-radiation Therapy for Malignant Abdominal Neoplasm in Infancy / M.Kaneko et al. / p319~319
  • General Lecture 119. Radiotherapy of Malignant Glioma with Fast Neutron / Y.Aoki et al. / p320~320
  • General Lecture 120. Brain Atrophy Following Radiation Therapy to the Brain / A.Asai et al. / p320~320
  • General Lecture 121. Multivariate Analysis of the Prognostic Factor in Glioblastoma Multiforme / K.Takahashi et al. / p320~320
  • General Lecture 122. Radiation Therapy of Brain Metastasis from Lung Cancer / K.Sato et al. / p321~321
  • General Lecture 123. Radiation Therapy to Germinoma / A.Akanuma et al. / p321~321
  • General Lecture 124. Radiation Therapy of Lymph Node Metastases in Patients with Larynx Carcinoma / M.Chatani et al. / p321~321
  • General Lecture 125. Radiotherapy of the Nasopharyngeal Squamous Cell Carcinoma / S.Yamashita et al. / p322~322
  • General Lecture 126. Radiotherapy of Hypopharynx Carcinoma:Special Reference for Nodal Control / T.Teshima et al. / p322~322
  • General Lecture 127. Role of Radiotherapy for Cancer of the Minor Salivary Gland / J.Horiuchi et al. / p322~322
  • General Lecture 128. Radiotherapy of Tongue Carcinoma / N.Watanabe et al. / p323~323
  • General Lecture 129. Electron Beam Therapy in Tongue Cancer / R.Kamata et al. / p323~323
  • General Lecture 130. The Role of Elective Neck Irradiation in the Treatment of Tongue Cancer / T.Kamada et al. / p323~323
  • General Lecture 131. Radioprotective Effect of Oral Cooling for Radiation Stomatitis / S.Hong et al. / p324~324
  • General Lecture 132. Clinical Trial of Radioprotective Drug,WR-2721 in Abdominal Radiotherapy / M.Ryu et al. / p324~324
  • General Lecture 133. Radiotherapy for the Biliary Tract Carcinoma / M.Kita et al. / p324~324
  • General Lecture 134. Evaluation of the Radiotherapy for Bile Duct Cancer / T.Kushibuchi et al. / p325~325
  • General Lecture 135. Radiotherapy for Hepatoma with Severe Cirrhosis / T.Okamura et al. / p325~325
  • General Lecture 136. Radiotherapy against Hepatic Carcinoma / K.Hatano et al. / p325~325
  • General Lecture 137. Evaluation of Intraoperative Irradiation for Pancreas Cancer / T.Shiina et al. / p326~326
  • General Lecture 138. Fast Neutron Radiotherapy of Advanced Carcinoma of the Lung at NIRS / S.Morita et al. / p326~326
  • General Lecture 139. Treatment of the Old Age Lung Cancer with Radiotherapy / T.Inomata et al. / p326~326
  • General Lecture 140. Developments in the Treatment of Advanced Lung Cancer / T.Sakurai et al. / p327~327
  • General Lecture 141. The Conformation Radiotherapy of Lung Cancer / M.Hatakeyama et al. / p327~327
  • General Lecture 142. Postoperative Radiation Therapy for Low-stage Renal Cell Carcinoma / A.Kashiwagi et al. / p327~327
  • General Lecture 143. Studies of Intraoperative Irradiation Therapy for Bladder Cancer / I.Kondo et al. / p328~328
  • General Lecture 144. Treatment of Primary Carcinoma of the Female Urethra / M.Maruoka et al. / p328~328
  • General Lecture 145. Radiation Therapy for stage B and stage C Carcinoma of the Prostate / T.Takahashi et al. / p328~328
  • General Lecture 146. Evaluation of Postoperative Radiotherapy by the Moving Strip Technique for Primary Ovarian Cancer (The Fourth Report) / M.Yorishima et al. / p329~329
  • General Lecture 147. Effects and Complications by Low Dose Rate Teletherapy as a Boost Therapy / S.Yamada et al. / p329~329
  • General Lecture 148. A New Radiation Treatment System with Fixed Multi-leaf Irregular Multi-port Technique and a Point Referring Patient Setup Method / Y.Aoki et al. / p329~329
  • General Lecture 149. Radiation Therapy and Diagnosis of Malignant Tumor Using a New Artificial Blood Substitute, Perfluoroctylbromide Emulsion (FOB) / Y.Hishikawa-Itoh et al. / p330~330
  • General Lecture 150. Sensitivity of a Human Renal Cell Carcinoma Xenograft in Nude Mice to Irradiation / T.Onishi et al. / p330~330
  • General Lecture 151. Changes of Estrogen Receptor before and after Chemo-endocrine Therapy for DMBA Induced Rat Mammary Carcinomas / M.Yamato et al. / p330~330
  • General Lecture 152. Hormone Receptor of Breast Cancer--Comparison of PAP and DCC Methods / K.Mochizuki et al. / p331~331
  • General Lecture 153. Adjuvant Chemo-endocrine Therapy for Androgen-dependent Mammary Tumor in Mice / S.Noguchi et al. / p331~331
  • General Lecture 154. Effects of Estrogen and Prolactin on Estrogen Receptors and Thymidine Kinase Isozyme Activities in DMBA-induced Rat Mammary Tumor / T. Kawasaki et al. / p331~331
  • General Lecture 155. Hormone Sensitivity Test with Human Cancer Cell Using RI Uptake on Milititer Plate / N.Miyazaki et al. / p332~332
  • General Lecture 156. Hormone Therapy for Recurrent Breast Cancer / Y.Murayama et al. / p332~332
  • General Lecture 157. Hormonal Therapies for the Patients with Advanced or Recurrent Breast Cancer / T.Tominaga et al. / p332~332
  • General Lecture 158. Therapeutic Effects of Medroxyprogesterone Acetate in Recurrent or Advanced Breast Cancer / M.Yoshida et al. / p333~333
  • General Lecture 159. Basic and Clinical Studies of Medroxyprogesterone Acetate(MAP)in Treatments of Advanced or Recurrent Human Breast Cancer and DMBA-induced Rat Mammary Cancer / Y.Iino et a1. / p333~333
  • General Lecture 160. Tamoxifen plus Tegafur versus Tamoxifen plus Tegafur plus Low-dose Adriamycin in a Treatment of Advanced Breast Cancer / T.Wada et a1. / p333~343
  • General Lecture 161. Preliminary Comparison between Chemo-,Chemo-endocrine-and Endocrine Therapy as an Adjuvant Treatment for Operable Breast Cancer / H.Tashiro et al. / p334~344
  • General Lecture 162. Clinical Signification of Parasternal Lymphoscintigram with ⁹⁹mTc-Renium Colloid / I.Yodoyama et al. / p334~334
  • General Lecture 163. Mammographic Diagnosis with Computed Radiography (FCR) / H.Fukushima et al. / p334~334
  • General Lecture 164. DSA(Digital Subtraction Angiography)through the Indwelling Catheter for Intra-arterial Chemotherapy / N.Kobayashi et al. / p335~335
  • General Lecture 165. Pathohlstological Study of Extrahepatic Bile Duct Carcinoma in Comparison with Percutaneous Transhepatic Cholangiogram (PTC) / Y.Koide et al. / p335~335
  • General Lecture 166.NMR in Neoplastic Tissue--From the Viewpoint of Water Proton Spinlattice Relaxation Time / I.Kimijima et al. / p335~335
  • General Lecture 167. Evaluation of Oral and Maxillofacial Malignant Tumors with CT Scan and RI Schintigraphy / T.Fukuda et al. / p336~336
  • General Lecture 168. Diagnosis of Hepatic Metastasis in Patients with Gastric Cancer:Reliability in Tumor Markers and Image Diagnosis / H. Kenmizaki et al. / p336~336
  • General Lecture 169. Comparative Study of Various Image Diagnoses against Renal Cellular Carcinoma / T.Omata et al. / p336~336
  • General Lecture 170. Tumor Associated Antigen of Squamous Cell Carcinoma of the Maxillary Sinus / M.Horiuchi et al. / p337~337
  • General Lecture 171. Clinical Studies of Tumor Markers in Thyroid Carcinomas / G.Kaneko et al. / p337~337
  • General Lecture 172. Serum Thyroglobulin Levels as a Thyroid Cancer Marker / Y.Abe et al. / p337~337
  • General Lecture 173. Serum Type I Procollagen Peptide and Collagen Producing Cell in the Patients with Scirrhous Carcinoma of Stomach / Y.Niitsu et al. / p338~338
  • General Lecture 174. Estrogen Staining in Breast Cancer,Comparing with CEA and Ferritin Staining / O.Kojima et al. / p338~338
  • General Lecture 175. Serum Levels of AFP and HCG in the Patients with Primary Intracranial Germ Cell Tumor / N.Arita et al. / p338~338
  • General Lecture 176. Serum CEA,hCG and AFP in Gastric Cancer / T.Sawa et al. / p339~339
  • General Lecture 177. Maximum Percentage Change of CEA and GCDFP-15 after Chemotherapy against Recurrent Breast Cancer / K.Enomoto et al. / p339~339
  • General Lecture 178. Not Received / /
  • General Lecture 179. Current Significance of Tumor Marker,AFP and HCG in Testicular Tumor / S.Sakashita et al. / p339~339
  • General Lecture 180. The Evaluation of Antitumor Effect of Chemotherapy from a Point View of Chronol-ogy(The Study of Time),Using Tumor Marker Levels of Serum / Y.Takahashi et al. / p340~340
  • General Lecture 181. Results of Every Second Year Examination in Mass Screening for Breast Cancer / K.Yoshida et al. / p340~340
  • General Lecture 182. The Mass Screening for Breast Cancer:Review of Interval Breast Cancer / A.Fujiwara et al. / p340~340
  • General Lecture 183. Breast Cancer Mass Screening Project in Kanagawa Prefecture: 5th Report / T.Tajima et al. / p341~341
  • General Lecture 184. Trial of Early Detection of Breast Cancer by Mass Screening in Miyagi Prefecture / R.Abe et a1. / p341~341
  • General Lecture 185. Diagnostic Value of the Nipple Discharge
  • Especially about a Relationship with a Breast Carcinoma / F.Yamakawa et al. / p341~341
  • General Lecture 186. Mass Screening for the Thyroid Cancer in Gunma Prefecture / T.Ishida et a1. / p342~342
  • General Lecture 187. Mass Screening for Colorectal Cancer by Occult Blood Testing under Restricted Diet / M.Fujita et al. / p342~342
  • General Lecture 188. Studies on Early Detection of Hepatocellular Carcinoma--HCC Cases Detected by Ultrasound Mass Survey and Subsequent Treatment Data / K.Hirata et al. / p342~342
  • General Lecture 189. The Realities of Cervical Intraepithelial Neoplasia in Young Women (Under Age 30) / M.Shiota et al. / p343~343
  • General Lecture 190. Mass-screening of Neuroblastoma and Its Incidence in Sapporo / T.Takeda et al. / p343~343
  • General Lecture 191. Histological Evaluation of the Effect of Adjunct Cancer Therapy / K.Kanazawa et a1. / p343~343
  • General Lecture 192. Immunocytochemical Localization of Kerain and Carcinoembryonic Antigen(CEA)in Carcinomas of the Uterine Cervix / Y.Okudaira et a1. / p344~344
  • General Lecture 193. Transformation of Mixed Germ Cell Tumor to Immature Teratoma Following Chemotherapy / T.Ihara et al. / p344~344
  • General Lecture 194. HCG Positive Cells in Non-seminomatous Germ Cell Testicular Tumor / S.Gotoh et al. / p344~344
  • General Lecture 195. Histologic Characteristics of Advanced Gastric Cancers Detected by Annual Mass Survey and Their Nuclear DNA Content / H.Nishidoi et al. / p345~345
  • General Lecture 196. Cytophotometric DNA-analysis as a Therapy Monitoring Method in Prostatic Cancer / K.Naito et al. / p345~345
  • General Lecture 197. Estrogen Receptor(ER)and Estrogen(E₂)in Gastric and Colo-rectal Cancers / A.Tokunaga et al. / p345~345
  • General Lecture 198. Not Received / /
  • General Lecture 199. Ultmstructural Studies on the Prostatic Cancer--With Serial Reference to Gestagen Therapy / K.Yoshida et al. / p346~346
  • General Lecture 200. Intrasplenic Ovarian Tumor--Relation with Gonadotropin / I.Otsu et al. / p346~346
  • General Lecture 201. A Histo-morphological Study of Mechanism of Stromal Proliferation in Krukenberg Tumor / T.Tazaki et al. / p346~346
  • General Lecture 202. Cancer of the Mesopharynx / H. Miyahara et al. / p347~347
  • General Lecture 203. Piriform Sinus Carcinoma(PSC)in Female / K.Yoshino et al. / p347~347
  • General Lecture 204. A Proposal of TNM Classification System for Cancer of the Salivary Gland--Comprehensive Retrospective Study / K.Hayasaki et al. / p347~347
  • General Lecture 205. Clinicopathological Study of Recurrent Breast Cancer / T.Sugawara et al. / p348~348
  • General Lecture 206. Bilateral Carcinoma of the Breast / Y.Murayama et al. / p348~348
  • General Lecture 207. Characteristics of Mammary Cancer without Mass / S.Itoh et al. / p348~348
  • General Lecture 208. A Study on the Invasive Type and Length of Esophagus from Upper Gastric Cancer / Y.Takiguchi et al. / p349~349
  • General Lecture 209. Clinicopathological Studies of Gastric Cancer with Liver Metastasis / Y.Kato et al. / p349~349
  • General Lecture 210. Clinicopathological Study of the Remnant Stomach Cancer / N.Katayanagi et al. / p349~349
  • General Lecture 211. Stomach Cancer Following Partial Gastrectomy for Benign Disease and Histological Changes of Remnant Stomach Mucosa / G.Nakano et al. / p350~350
  • General Lecture 212. Studies of 7 Cases of Primary Cancer of Remnant Stomach / K.Sakuramoto et al. / p350~350
  • General Lecture 213. Clinicopathological Studies in 35 Cases of Resected Distal Bile Duct Cancer / S.Uematsu et al. / p350~350
  • General Lecture 214. A Clinicopathological Study for Six Resected Cases of Intrahepatic Bile Duct Carcinoma / Y.Yamamoto et al. / p351~351
  • General Lecture 215. Clinical Evaluation of Colorectal Carcinomas with Liver Metastases / T.Sekine et al. / p351~351
  • General Lecture 216. An Analysis of the Development Form of Mucinous Carcinoma on the Colon and Mucinous Cystadenocarcinoma on the Appendix / M.Nakamura et al. / p351~351
  • General Lecture 217. The Clinicopathologic Study of Adenocarcinoma of the Cervix / M.Imachi et al. / p352~352
  • General Lecture 218. Cytopathological Analysis of Uterine Cervical Cancer, So-called Ib"occ" / K.Katoh et al. / p352~352
  • General Lecture 219. The Prognosis of Endometrial Cancer in Cytohistological Study / H.Shirasawa et al. / p352~352
  • General Lecture 220. Morphological Studies on Microscopic Mole / K.Ito et al. / p353~353
  • General Lecture 221. Non-Hodgkin's Lymphomas Involving Waldeyer's Ring / N.Hayabuchi et al. / p353~353
  • General Lecture 222. Clinicopathologic Study of Thyroid Carcinoma Infiltrating the Trachea / T.Tsumori et al. / p353~353
  • General Lecture 223. Histological Evaluation of Metastasis in Renal Cell Carcinoma I,Comparison of Primary and Metastatic Lesions / M.Fukuda et al. / p354~354
  • General Lecture 224. Clinico-Pathological Studies of Prostatic Carcinoma (7) :Study of Unsuspected Carcinoma on the Suprapubic Prostatectomy Specimens / M.Harada et al. / p354~354
  • General Lecture 225. Reevaluation by Gleason's Grading to the Cases of Prostatic Cancer / Y.Furukawa et al. / p354~354
  • General Lecture 226. The Surgical Management of Lung Metastases / M.Hashimoto et al. / p355~355
  • General Lecture 227. Surgery for Pulmonary Metastasis (Breast Cancer & Osteogenic Sarcoma) / S.Mizoguchi et al. / p355~355
  • General Lecture 228. Surgical Treatment of Pulmonary Metastasis of Malignant Tumors / M.Imaizumi et al. / p355~355
  • General Lecture 229. Surgical Treatment for Metastatic Lung Cancer / H.Ayabe et al. / p356~356
  • General Lecture 230. Surgical Treatment of Metastatic Lung Cancer / H.Kimura et al. / p356~356
  • General Lecture 231. Survival Following Resection of Pulmonary Metastasis from Osteogenic Sarcoma. / S.Fukai et al. / p356~356
  • General Lecture 232. Role of Pulmonary Resection in the Management of Patients with Metastatic Bone and Soft Tissue Sarcomas / K.Amino et al. / p357~357
  • General Lecture 233. Prognosis of Operation for Pulmonary Metastasis of Choriocarcinoma / M.Takayama et al. / p357~357
  • General Lecture 234. Surgical Treatment of Metastatic Pulmonary Tumor from the Urinary Bladder / M.Kuroda et al. / p357~357
  • General Lecture 235. Studies on the Time of Development of Liver Metastases and Their Surgical Management / I.Mizuno et al. / p358~358
  • General Lecture 236. Repeated Operation for Metastatic Liver Tumor / S.Iida et al. / p358~358
  • General Lecture 237. Treatment and Results of Hepatic Metastases from Gastric and Colorectal Cancer / H.Mizutani et al. / p358~358
  • General Lecture 238. The Treatment of Ovarian Cancer with Malignant Pleural Effusion and Metastatic Liver Cyst / R.Tzeng et al. / p359~359
  • General Lecture 239. Surgery for Metastatic Brain Tumors / H.Yamamoto et al. / p359~359
  • General Lecture 240. A Clinical and Statistical Study of Cervical Lymphnode Metastases of Tongue Cancer / S.Iwamoto et al. / p359~359
  • General Lecture 241. Surgical Treatment for Thyroid Cancer Associated with Hematogenic Metastatic Lesion / J.Sasaki et al. / p360~360
  • General Lecture 242. Clinical Study of the Breast Cancer Patients with Ovarian or Adrenal Metastases / A.Sawano et al. / p360~360
  • General Lecture 243. Aggressive Surgeries for Metastases of Testicular Tumors / S.Ichijo et al. / p360~360
  • General Lecture 244. Breast Cancer Recurrence in the Parasternal Region and Its New Surgical Manage-ment / M.Noguchi et al. / p361~361
  • General Lecture 245. A Cross-over Study of Lorazepam and Domperidone in Gastrointestinal Symptoms Associated with Cytostatics / R.Kumai et al. / p361~361
  • General Lecture 246. Randomized Controlled Study of High-dose Dexamethasone(H-Dex.)with or without Domperidone(Domp.)in Cis-DDP Induced Emesis / M.Murakami et al. / p361~361
  • General Lecture 247. Randomized Control Trial against CDDP-induced Emesis / Y.Funaki et al. / p362~362
  • General Lecture 248. Corticosteroid as an Antiemetic on Chemotherapy with Cis-Diamminedichloroplatinum(II) (CDDP) / S.Samma et al. / p362~362
  • General Lecture 249. Randomised Antiemetic Trials with Betamethasone, Methylprednisolone in Patients Receiving CDDP-Containing Chemotherapy / K. Matsui et al. / p362~362
  • General Lecture 250. Experimental Evaluation of Effects of Methylpredonisoione to CDDP / N.Tsuboi et al. / p363~363
  • General Lecture 251. 2 Channel Infusion Chemotherapy / N.Mitsuhata et al. / p363~363
  • General Lecture 252. "Two Route Infusion Chemotherapy" for Liver Cancer and Peritonitis Carcinomatosa / R.Abe et al. / p363~363
  • General Lecture 253. Two Channels Infusion Therapy with CDDP for Head and Neck Cancers / K.Toda et al. / p364~364
  • General Lecture 254. Systemic Chemotherapy of Cisplatin(DDP)with Sodium Thiosulfate(STS)Rescue:Experimental and Clinical Studies / K.Lee et al. / p364~364
  • General Lecture 255. Basic Study on Fosfomycin Using Cisplatin Treatment / K.Tanaka et al. / p364~364
  • General Lecture 256. Cisplatin-Induced "Mallory-Weiss"Syndrome / H.Majima et al. / p365~365
  • General Lecture 257. Maximum Dose and Evaluation of Side Effect of Cis-DDP in Advanced Neuroblas-toma of Children / K.Sue et al. / p365~365
  • General Lecture 258. Preventive Effect of Hydration on CDDP-induced Nephrotoxicity / H.Sakatoku et al. / p365~365
  • General Lecture 259. Problems as to the Therapeutic Procedure for Nephroblastoma Regarding Side Effect of Therapeutic Agents / S.Ishizone et al. / p366~366
  • General Lecture 260. Pre-and Post-Treatment Semen and Hormone Analyses in Testicular Cancer / T.Miyauchi et al. / p366~366
  • General Lecture 261. Risk Factors in Interstitial Pneumonia Following Allogeneic Bone Marrow Transplan-tation for Acute Leukemia A Co-operative Study from the TBI Subcommittee in Japan / T.Inoue et al. / p366~366
  • General Lecture 262. Clinical Study of Combination Chemotherapy with CDDP, 5-FU and MMC for Various Adenocarcinomas (PFM Therapy) / T.Goto et al. / p367~367
  • General Lecture 263. Combination Chemotherapy of Non-Small Cell Lung Cancer with Cisplatin and Vinblastine / K.Aiba et al. / p367~367
  • General Lecture 264. Randomized Comparison of CDDP • VDS versus CDDP • ACNU in the Treatment of Non-Small Cell Lung Cancer / A.Yoshimura et al. / p367~367
  • General Lecture 265. Cisplatin, Peplomycin, Mitomycin C and Vincristine Combination Chemotherapy of Non-Small Cell Lung Cancer / H.Saito et al. / p368~368
  • General Lecture 266. Phase II Studies of Several Anticancer Agents in Metastatic Pulmonary Tumors / J.Fujita et al. / p368~368
  • General Lecture 267. Combination Effects of CDDP and Peplomycin on Esophageal Carcinoma / N.Ando et al. / p368~368
  • General Lecture 268. Phase II Study of CDDP Indicated as Subsequent Chemotherapy against Far Advanced Gastric Cancer / A.Hijikata et al. / p369~369
  • General Lecture 269. Antitumor Effect of Combined Cis-platinum, Adriamycin, Cyclophosphamide Therapy against Metastatic Cancer / M.Takada et al. / p369~369
  • General Lecture 270. Effect of Cis-platinum in Single and Multiple Drug Combination Use in the Treatment of Advanced Childhood Solid Tumors / M.Ohira et al. / p369~369
  • General Lecture 271. Phase II Studies of Mitoxantrone(MIT),Etoposide(ETP),and Cisplatin(CDDP) And a Phase III Study of a 4-drug Combination of MIT,ETP,CDDP and Prednisolone(PDS)in Malignant Lymphoma Patients / K.Ueno et al. / p370~370
  • General Lecture 272. Chemotherapy for and Prognosis of Breast Cancer with Lymphatic Metastasis / Y.Hara et al. / p370~370
  • General Lecture 273. Combination Effects of Peplomycin and Adriamycin for Advanced and Recurrent Breast Cancer / Y.Kondo et al. / p370~370
  • General Lecture 274. Studies of Combined Chemotherapy for Malignant Tumor in Internal Medicine / Y.Imamura et al. / p371~371
  • General Lecture 275. Intermittent Adjuvant Chemotherapy for Breast Cancer / M.Numata et al. / p371~371
  • General Lecture 276. Local Therapy of the Breast Cancer by Adriamycin Ointment -The 2nd Report / K.Katayama et al. / p371~371
  • General Lecture 277. Combination Effects of CDDP,ACR and HCFU on Progressive Urothelial Tumors / K.Ueda et al. / p372~372
  • General Lecture 278. Sequential Intravesical Chemotherapy with Mitomycin C and Adriamycin for Superficial Bladder Tumor (Preliminary Report) / I.Fukui et al. / p372~372
  • General Lecture 279. Postoperative Prophylactic Intravesical Instillation of Carboquone in Superficial Bladder Tumors / T.Ueda et al. / p372~372
  • General Lecture 280. Clinical Effects of the Combination Chemotherapy for Hormone Refractory Advanced Prostatic Cancer / T.Muromoto et al. / p373~373
  • General Lecture 281. Ifosfamide Treatment for 5 Cases of Relapsed Prostatic Cancer / T.Kobayashi et al. / p373~373
  • General Lecture 282. Phase II Study on Oral Administration of NK171(Etoposide)in Lung Cancer / H.Ikegami et al. / p373~373
  • General Lecture 283. A Phase II Study of Oral VP-16 in Primary Lung Cancer / Y.Matsui et al. / p374~374
  • General Lecture 284. Phase II Study of a Semisynthetic Podophyllotoxin VP16-213 in Lymphogenous Malignancies / T.Kojima et al. / p374~374
  • General Lecture 285. VP-16 Salvage Therapy for Refractory Testis Tumors / Y.Akasaka et al. / p374~374
  • General Lecture 286. Not Received / /
  • General Lecture 287. Phase II Study of VP-16-213 for Malignant Solid Tumors with Special Reference to Hepatoma / S.Meguro et al. / p375~375
  • General Lecture 288. Clinical Studies on Etoposide(NK-171)for Trophoblastic Disease / S.Honma et al. / p375~375
  • General Lecture 289. Clinical Trial of Etoposide for Advanced Non-small Cell Lung Cancer / K.Eguchi et al. / p375~375
  • General Lecture 290. Combination Effect of K18 and Other Conventional Chemotherapeutic Agents against Human Tumors Transplanted in Nude Mice / K.Nakatani et al. / p376~376
  • General Lecture 291. Synthetic Antitumor Agent K18, Its Fundamental and Clinical Studies(I) / S.Fuchimoto et al. / p376~376
  • General Lecture 292. Experimental and Clinical Researches of Antitumor Drug, K18 / K.Terabe et al. / p376~376
  • General Lecture 293. A Clinical Trial of K-18(IgG-Melphalan)in Relapsed Patients with Hematological Malignancies / Y.Kanakura et al. / p377~377
  • General Lecture 294. Phase II Studies of MMC and KW2083(MMC Derivative)in Non Small Cell Lung Cancer / S.Negoro et al. / p377~377
  • General Lecture 295. Phase II Study of KW-2083 on stage D prostatit cancer / J.Yoshimoto er al. / p377~377
  • General Lecture 296. Clinical Studies on Bestrabucil(KM2210),a Target Oriented Anticancer Drug, in Patient with Recurrent and Advanced Breast Cancer / Z.Yamazaki et al. / p378~378
  • General Lecture 297. Clinical Trials of Lactobacillus Casei YIT 9018 (LC 9018) / H.Inaba et al / p378~378
  • General Lecture 298. The Effects of Combination Chemotherapy "M-VEMFH" Including Mitoxantorone(MXN)for Advanced Breast Cancer / Y.Ito et al. / p378~378
  • General Lecture 299. Effect of Copper-Tripeptide Complex and Ascorbate on Tumor Cells in Tissue Culture A Morphological Study / N.Ohtsu et al. / p379~379
  • General Lecture 300. Phase II Study on TK-117--Especially for the Effect against Gastric Cancer / H.Suzuki et al. / p379~379
  • General Lecture 301. Phase II Study on SF-SP (Orally Administrated Spansule Tegafur) / K.Kimura et al. / p379~379
  • General Lecture 302. Study on Slow Releasing Anticancer Agent--Needle Shaped Compound of 5-FU and Polylactic Acid / R.Yamashita et al. / p380~380
  • General Lecture 303. In vitro Phase II Study of New Anthracycline-Anthraquinone Analogues Using the Tumor Stem Cell Assay / T.Numata et al. / p380~380
  • General Lecture 304. Comparative Study of Three Anthracyclines,on the Clinical Effect and the Adverse Effect / T.Takahashi et al. / p380~380
  • General Lecture 305. Kinetics of i.v. Administration of 4'-epi-Adriamycin(4'-epi-ADM)and Its Anti-tumor Effect toward Pulmonary Carcinoma and Malignant Lymphoma / T.Ohno et al. / p381~381
  • General Lecture 306. A New Anticancer Agent with Topical Stay and a Sustained Release / A.Sugitachi et al. / p381~381
  • General Lecture 307. Study on Slow Release Anticancer Agent,5FU-polylactic Acid Microcapsule / M.Sakatoku et al. / p381~381
  • General Lecture 308. Fibrin Clot Containing Anticancer Drug as a New Embolus for Intraarterial Chemoembolization Therapy / J.Itoh et al. / p382~382
  • General Lecture 309. Experimental Pig's Hepatic Artery Embolization with Ivalon Particles / M.Fujita et al. / p382~382
  • General Lecture 310. Anticancer Effects of Lipiodol • adriamycin Suspension for Hepatocellular Carcinoma--Comparison between Resected Specimen and Soft X-ray Figure / Y.Sasaki et al. / p382~382
  • General Lecture 311. Clinical Evaluation of Ferromagnetic Microembolization in Hepatoma--As Compared to That of Gelatin Sponge Embolization / S.Ohtsuki et al. / p383~383
  • General Lecture 312. Transcatheter Chemoembolization for Encapsulated Hepatoma (≦5 cm) / H.Nakamura et al. / p383~383
  • General Lecture 313. A Clinical and Experimental Study of the Infusion Chemotherapy and Embolization after the Intermittent Hepatic Artery Occlusion (IHAO) for the Unresectable Hepatocellular Carcinoma (HCC) / A.Naitoh et al. / p383~383
  • General Lecture 314. Indication and Technique of Surgical Embolization Therapy for Liver Cancer / S.Sakumoto et al. / p384~384
  • General Lecture 315. Effective Control of Hepatic Hemorrhage in Patients with Rupture of Hepatocellular Carcinoma by Transcatheter Arterial Embolization / Y.Kawazoe et al. / p384~384
  • General Lecture 316. Influence of Pre-operative Managements on the Prognosis of Patients with Stage III Breast Cancer / Y.Takatsuka et al. / p384~384
  • General Lecture 317. Effect of Preoperative Embolization for Renal Cell Carcinoma Followed by Curative Operation / K.Yoneda et al. / p385~385
  • General Lecture 318. Effects of Various Kinds of Interferons on Lung Cancer Cell Lines in Human Tumor Clonogenic Assay / Y.Sasaki et al. / p385~385
  • General Lecture 319. Antitumor Effects of α-interferon on Renal Cell Cancer by Clonogenic Assay / T.Hashimura etal. / p385~385
  • General Lecture 320. Evaluation of Interferon-αA against Human Renal Cell Carcinomas in Clonogenic Assay / K.Ohmura et al. / p386~386
  • General Lecture 321. Investigation of the Anti-Tumor Effect by Various Types of IFN: Use of the Primary Urological Tumors and the Established Cancer Cell Lines / H.Matsuyama et al. / p386~386
  • General Lecture 322. Comparison of Effects of Human α, β and γ Interferons on in vitro Natural Killer Activity / H.Matsumoto et al. / p386~386
  • General Lecture 323. Effects of in vivo Administration of Recombinant β-interferon and Natural γ-interferon on the Immunity of Peripheral Blood Lymphocytes in Cancer Patients / J.Yamada et al. / p387~387
  • General Lecture 324. The Effects for Human Lymphoblastoid Interferon(HLBI)against Human Renal Cell Carcinomas Transplanted into Nude Mice(AM-RC-2,AM-RC-3) / Y.Yamada et al. / p387~387
  • General Lecture 325. Combination Effects of Interferon-α and 5-FU or CDDP on Murine Bladder Cancer / S.Kameyama et al. / p387~387
  • General Lecture 326. Antitumor Effects of Human Immuno Interferon (IFN-γ) on Ovarial Cancer Implant-ed into Nude Mice / K.Miyahara et al. / p388~388
  • General Lecture 327. Clinical Trials of Natural(N-)or Recombinant(R-)Interferon(IFN)-α,-β,and -γ in Cancer Patients / Y.Mitachi et al. / p388~388
  • General Lecture 328. Effects of Human Lymphoblastoid Interferon(HLGI)in Patients with Hematological Neoplasms / Y.Oda et al. / p388~388
  • General Lecture 329. Combination Therapy with HuIFN-β and ACNU against Malignant Brain Tumors / J.Yoshida et al / p389~389
  • General Lecture 330. Treatment of Hepatocellular Carcinoma(HCC)with Combination Interferon-β(IFN),Adriamycin(ADR)and Mitomycin C(MMC) / T.Okai et al. / p389~389
  • General Lecture 331. The Treatment of Renal Cell Carcinoma with Human Lymphoblastoid Alpha-Interferon / T.Kinouchi et al. / p389~389
  • General Lecture 332. Clinical Study of IFL-rA(Ro 22-8181)to Various Urogenital Cancer Patients / T.Matsumoto et al. / p390~390
  • General Lecture 333. Alpha-interferon in the Therapy of Primary Lung Cancer and Metastatic Renal Carcinoma in the Lungs / S.Ryu et al. / p390~390
  • General Lecture 334. Chemotherapy for Metastatic Renal Cell Carcinoma / S.Isaka et al. / p390~390
  • General Lecture 335. Chemotherapy of Renal Cell Carcinoma 5.Combination Chemotherapy with α-interferon and Anticancer Drugs / Y.Satomi et al. / p391~391
  • General Lecture 336. Assessment of Diagnostic Values of Five Tumor Markers / D.Tsujino et al. / p391~391
  • General Lecture 337. The Use of CA19-9and Other Tumor Markers in Patients with Gastroenterological Cancer / T.Mure et al. / p391~391
  • General Lecture 338. Evaluation of CA 19-9,CEA,POA,Ferritin and Beta MG as a Marker of Pancreatic and Biliary Tract Cancer / K.Nishida et al. / p392~392
  • General Lecture 339. What is the Best Tumor Marker for Carcinoma of the Pancreas? / E.Harada et al. / p392~392
  • General Lecture 340. Clinical Examination of Tumor Marker--CA19-9,POA and Others / M.Suminaga et al. / p392~392
  • General Lecture 341. Clinical Evaluation of CEA,TPA and Acute Phase Reactant Proteins (APR) / K.Ogoshi et al. / p393~393
  • General Lecture 342. Immunocytological Evaluation of the Cancer Associate Antigen(TA-4)for Patho-clinical Management of the Cervical Malignancy / M.Hoshina et al. / p393~393
  • General Lecture 343. Serum TA-4 Values and Spread of Uterine Cervical Cancer / K.Shibata et al. / p393~393
  • General Lecture 344. The Clinical Evaluation of Tissue Localization of Tumor-markers in Ovarian Cancer / T.Tanimura et al. / p394~394
  • General Lecture 345. Comparison of IAP with α₁-AG and Other Tumor Markers in Gynecological Malignant Tumors / T.Hirata et al. / p394~394
  • General Lecture 346. Immunoperoxidase Staining of CEA and hKP(Human Keratin Protein)in His-tological and Cytological Specimens of Uterine Cancer / K.Fukuda et al. / p394~394
  • General Lecture 347. Serum Immunosuppressive Substance(IS)in Patients with Gynecologic Malignancies and Pregnant Women / K.Yamashita et al. / p395~395
  • General Lecture 348. Study on Serum Sialic Acid in Patients with a Colorectal Cancer / F.Yamakawa et al. / p395~395
  • General Lecture 349. Carcinoembryonic Antigen in Gastric Cancer Patients / N.Shimizu et al. / p395~395
  • General Lecture 351. Evaluation of Carcinoembryonic Antigen(CEA)in Patients with Colorectal Cancer / A.Ohashi et al. / p396~396
  • General Lecture 352. Carcinoembryonic Antigen Changes of Patients with Small Cell Lung Cancer during Treatment / M.Takada et al. / p396~396
  • General Lecture 353. The Value of Carcinoembryonic Antigens in Patients with Advanced Lung Cancer:In Relation to Chemotherapy / T.Shinkai et al. / p396~396
  • General Lecture 354. Clinical Application of the PFK (EC2.7.1.11) -Inhibition Test for Cancer Patients / H.Ogiwara et al. / p397~397
  • General Lecture 355. Clinical Application of Phosphofructokinase(PFK)Inhibition Test for Malignant Diseases in Urogenital Organs / K.Kobayashi et al. / p397~397
  • General Lecture 356. Significance of Lectin-binding Sites on Human Brain Tumors / T.Hori et al. / p397~397
  • General Lecture 357. Radioiodinated Peanut Agglutinin:A Potential New Tumor Seeking Agent / K.Yokoyama et al. / p398~398
  • General Lecture 358. Immunoperoxidase Staining for Pancreatic Oncofetal Antigen(PoA)in Pancreatic Cancer and Duct Hyperplasia / S.Uematsu et al. / p398~398
  • General Lecture 359. Measurement of the Prostatic Acid Phosphatase by the Radioimmuno Assay / S.Kanai et al. / p398~398
  • General Lecture 360. Immunoadsorbent Assay for Serum Prostatic Acid Phosphatase of Mass Examination System for the Prostatic Carcinoma / Y.Sato et al. / p399~399
  • General Lecture 361. Changes of Serum Prostatic Acid Phosphatase and γ-Seminoprotein Levels in Surgery of the Prostate / K.Matsuki et al. / p399~399
  • General Lecture 362. Clinical Evaluation of γ-Seminoprotein(γ-Sm)in the Patients with Prostate Cancer:(2)Serum γ-Sm Levels in Urological Diseases and Comparison with Prostatic Acid Phosphatase / I.Shinoda et al. / p399~399
  • General Lecture 363. Urinary Hydroxyproline Excretion as a Marker of Bone Metastases in Prostatic Cancer / K.Rinsho et al. / p400~400
  • General Lecture 364. NAG and AAP in Renal and Urinary Tract Tumors / T.Tsukada et al. / p400~400
  • General Lecture 365. Immunohistochemical Detection of T Antigen and ABH Blood Group Antigens in Upper Urinary Tract Cancer / H.Takigawa et al. / p400~400
  • General Lecture 366. Tumor Marker in Bladder Cancer / Y.Kamei et al. / p401~401
  • General Lecture 367. The Clinical Value of Serum Tumor Markers in Germinal Testicular Cancers / T.Miki et al. / p401~401
  • General Lecture 368. Clinical Study of Testicular Tumors--Clinical Reevaluation of Tumor Marker / A.Furuhata et al. / p401~401
  • General Lecture 369. The Role of Basic Fetoprotein(BFP)in Testicular Cancer / K.Harada et al. / p402~402
  • General Lecture 370. Pharmacokinetic Study on the Effect and Side Effect of Intra-arterial Injection Chemotherapy to Advanced Breast Cancer / H.Iwasaki et al. / p402~402
  • General Lecture 371. Low Dose-intermittent Intraarterial Infusion Chemotherapy Using a Subcutaneously Implanted Silicone Reservoir / Y.Arai et al. / p402~402
  • General Lecture 372. Pharmaco-dynamic Intraarterial Chemotherapy (Intraarterial Chemotherapy with Nor-adrenalin)--Histological Evaluation and Prognosis / T.Sato et al. / p403~403
  • General Lecture 373. Tumor Targeting by the Arterial Administration of [¹⁴C] Lipids in Rabbits with VX-2Carcinoma of the Liver / K.Iwai et al. / p403~403
  • General Lecture 374. Intermittent Intra-arterial Infusion Chemotherapy for Patients with Inoperable Car-cinoma of the Pancreatic Body and Tail / O.Ishikawa et al. / p403~403
  • General Lecture 375. Effect of Intra-Arterial Infusion Chemotherapy on Primary Advanced Breast Cancer / K.Toda et al. / p404~404
  • General Lecture 376. Clinical Evaluation of Intraarterial Infusion of Adriamycin on Locally Advanced Primary Breast Cancer / H.Yamamoto et al. / p404~404
  • General Lecture 377. Fundamental and Clinical Research on Uterine Arterial Infusion of Cisplatin / T.Izutsu et al. / p404~404
  • General Lecture 378. Selective Intra-arterial Infusion of Cis-diamminedichloroplatinum (CDDP) to the Metastatic Tumors of Ovarian Cancer / I.Tateyama et al. / p405~405
  • General Lecture 379. Pre-operative Isolation Perfusion Chemotherapy with Cisplatin in Osteosarcoma / S.Takeyama et al. / p405~405
  • General Lecture 380. Arterial Infusion Chemotherapy with Occlusion Balloon Catheter in Bladder Cancer / K.Mitsuzane et al. / p405~405
  • General Lecture 381. Transcatheter Chemoembolization of Vesical Artery for Superficial Bladder Cancer / S.Kimura et al. / p406~406
  • General Lecture 382. Balloon Occluded Arterial Infusion as Adjuvant Chemotherapy for Patients with Bladder Tumor / T.Yoshida et al. / p406~406
  • General Lecture 383. Ischemic Therapy of the Bladder Cancer / M.Honda et al. / p406~406
  • General Lecture 384. Reevaluation of Chemotherapeutic Agents for Intraarterial Infusion to Urinary Bladder Tumor with Reference to Tissue Concentration / Y.Kubota et al. / p407~407
  • General Lecture 385. Concomitant Chemotherapy Consisting of Neocarcinostatin Arterial Infusion and Other Anticarcinogenic Agents Administration / M.Yuasa et al. / p407~407
  • General Lecture 386. Selective Continuous Intra-arterial Infusion Therapy for Head and Neck Tumors / T.Hattori et al. / p407~407
  • General Lecture 387. Cisplatin-microcapsule Chemoembolization for Head and Neck Cancer / Y.Okamoto et al. / p408~408
  • General Lecture 388. Study on Intra-Arterial Lipiodol-Adriamycin Therapy for Malignant Liver Cancer / T.Nagashima et al. / p408~408
  • General Lecture 389. Hepatic-arterial Infusion of Oil-suspended Anticancer Agents Using Lipiodol for Malignant Hepatic Tumors / H.Hidaka et al. / p408~408
  • General Lecture 390. Intra Arterial Infusion Chemotherapy of Liposomes Containing Adriamycin(Chemoliposome)for Unresectable Liver Metastases from Gastric Cancer / H.Konno et al. / p409~409
  • General Lecture 391. Analysis of Recurred Ovarian Cancer Patients on Second and Third Look Lapa-rotomies / H.Nishiura et al. / p409~409
  • General Lecture 392. Analysis of Prognosis Benefit Factors in Treatment of Malignant Tumor of the Ovary / M.Nakayama et al. / p409~409
  • General Lecture 393. Treatment of Ovarian Carcinomas and Their Prognosis / H.Kawauchi et al. / p410~410
  • General Lecture 394. Clinical Study of Adenocarcinoma of the Uterine Cervix / K.Yoshida et al. / p410~410
  • General Lecture 395. Vaginal Recurrence of Endometrial Carcinoma / K.Inafuku et al. / p410~410
  • General Lecture 396. Simple Hysterectomy for stage Ia Carcinoma of the Uterine Cervix / N.Tsukamoto et al. / p411~411
  • General Lecture 397. Clinical Study of Cervical Cancer(Ia, CIS)in Oita Prefectural Hospital / I.Taniguchi et al. / p411~411
  • General Lecture 398. Treatment of Young Patients with Uterine Cervix Cancer and Pregnancy / H.Nakachi et al. / p411~411
  • General Lecture 399. A Study of Proper Excisional Margine in Therapeutic Conization / Y.Sakaguchi et al. / p412~412
  • General Lecture 400. Study on the Prognosis of the Uterine Endometrial Carcinoma / T.Kasamatsu et al. / p412~412
  • General Lecture 401. Significance of Noncurative Resection on stage IV Gastric Carcinoma / S.Kanabe et al. / p412~412
  • General Lecture 402. Some Problems on the Treatment of Gastric Cancer from the Standpoint of Follow-up Studies / H.Ueda et al. / p413~413
  • General Lecture 403. Problem in the Treated for Borrmann's Type 4 Gastric Cancer / S.Tamura et al. / p413~413
  • General Lecture 404. Upper G.I.Surgery and Postoperative Respiratory Function--The Effectiveness of the Transverse Incision / H.Hanaue et al. / p413~413
  • General Lecture 405. Clinico-pathological Investigation of Long-term Prognosis Subsequent to Gastric Carcinoma Resection / H.Takamura et al. / p414~414
  • General Lecture 406.Gastric Cancers in the Middle Age / H.Furukawa et al. / p414~414
  • General Lecture 407.A Study of Rectum Cancer by Age--Mainly about Rectum Cancer in Young Patients / M.Kanai et al. / p414~414
  • General Lecture 408.Colonic Cancer:A Comparison between Young and Elderly Patients / K.Saeki et al. / p415~415
  • General Lecture 409.Exploratory Laparotomy before the Radiotherapy for Uterine Cervical Cancer / T.Matsuyama et al. / p415~415
  • General Lecture 410.Tumor Cell Kinetics in Uterine Cervical Carcinoma following Irradiation Combined with PSK Administration / Y.Hayashi et al. / p415~415
  • General Lecture 411.Radiation Changes in Uterine Cervical Carcinomas Evaluated by Microspectro-photometry / H.Casanova et al. / p416~416
  • General Lecture 412.Local Control Rate and Rectal Injury of Carcinoma of the Uterine Cervix Using a Low-Dose-Rate Remote Afterloader (Gynatron) / Y.Tanaka et al. / p416~416
  • General Lecture 413.Retrospective Analyses of Local Control and Complications in RALS in Therapy of Cancer of Uterine Cervix / T.Nakano et al. / p416~416
  • General Lecture 414.Effect of Dose Variation at Point A in High Dose Rate Intracavitary Irradiation(RALSTRON)in Uterine Cervix Cancer / Y.Kikuchi et al. / p417~417
  • General Lecture 415.Combined Therapy of Synthesized Calcitonin and Irradiation on Metastatic Bone Tumors / M.Minami et al. / p417~417
  • General Lecture 416.Effects of Radiotherapy of Metastatic Bone Tumor / T.Mamiya et al. / p417~417
  • General Lecture 417.Management of Recurrent Breast Cancer / Y.Murakami et al. / p418~418
  • General Lecture 418.Radiotherapy of Non-Hodgkin's Lymphoma / H.Shirato et al. / p418~418
  • General Lecture 419.The Experience of Large Field Irradiation and Staging Laparotomy in Early Hodgkin's Disease / M.Uematsu et al. / p418~418
  • General Lecture 420.A Study on Estrogen Receptor in Uterocervical Cancer / R.Yamauchi et al. / p419~419
  • General Lecture 421.Flow Cytometric Analysis of Action of Progestogen to the Patients with Adenocar-cinoma and Its' Precancerous Lesions of the Endometrium / I.Nishiya et al. / p419~419
  • General Lecture 422.An Experimental Evaluation of Hormone-therapy for Ovarian Adenocarcinoma in Rat / H.Katabuchi et al. / p419~419
  • General Lecture 423.Effects of Steroid Hormones and Diethylstilbestrol on Cell Cycle of Cultured Human Prostatic Adenocarcinoma (PC-3) / K.Yokota et al. / p420~420
  • General Lecture 424.Treatment of Prostatic Cancer with LH-RH Agonist-Polymer Composite / K.Imai et al. / p420~420
  • General Lecture 425.Antiandrogen Therapy for Carcinoma of the Prostate / K.Fukutani et al. / p420~420
  • General Lecture 426.Combination Chemotherapy of Vincristine, Ifosfamide and Peplomycin in the Patients with Advanced stage D Adenocarcinoma of the Prostate / T.Obama et al. / p421~421
  • General Lecture 427. Lymphocyte Subsets in Patients with Lung Cancer / M.Aoki et al. / p421~421
  • General Lecture 428. T-Cell Subsets of Peripheral Blood and Lymph Node in Patients with upper GI Tract Cancer / G.Shirozu et al. / p421~421
  • General Lecture 429. Immunodepression and Suppressor Cell Activity in Esophageal Cancer Patients / T.Saito et al. / p422~422
  • General Lecture 430. Evaluation of Immunity in Gastric and Colon Cancers (Study on T-cell Subset Using Monoclonal Antibody) / Y.Fukurnoto et al. / p422~422
  • General Lecture 431. Effect of Cyclophosphamide(CPM)on Surface Markers of Peripheral Blood Lymphocytes in the Patients with Breast Cancer / M.Kimura et al. / p422~422
  • General Lecture 432. Suppressor Cell Activities of Peripheral Blood Lymphocyte in Breast Cancer Patients / Y.Hamada et al. / p423~423
  • General Lecture 433. A Study on T-Cell Subpopulation of Regional Lymph Nodes Obtained from Gastric Cancer Patients / K.Yakushiji et al. / p423~423
  • General Lecture 434. Immunity of Regional Lymphnode Lymphocytes in Gastric Cancer / T.Yokoyama et al. / p423~423
  • General Lecture 435. Effects of BRM on NK Activity of Regional Lymph Node Cells in Patients with Gastric Cancer / F.Koba et al. / p424~424
  • General Lecture 436. Immunological Studies on Regional Lymph Nodes of Early Breast Cancer / R.Abe et al. / p424~424
  • General Lecture 437. Immunological Significance of Splenectomy in Gastric Cancer Surgery / H.Kanayama et al. / p424~424
  • General Lecture 438. The Role of the Spleen under Immunochemotherapy against Cancer / S.Taketsuka et al. / p425~425
  • General Lecture 439. Study of IL-2 Activity in Peripheral Blood Lymphocytes of Patients with Brain Tumors / S.Yoshida et al. / p425~425
  • General Lecture 440. Induction of Lymphokine-activated Killer(LAK)Cells from Spleen Combined Gastrectomy for Gastric Cancer and.Prospects of Its Utilization for Adoptive Im-munotherapy / K.Okuno et al. / p425~425
  • General Lecture 441. Effect of Local Injection of OK-432 on the Responsiveness to Interleukin-2(IL-2)in Cervical Cancer / K.Yamamoto et al. / p426~426
  • General Lecture 442. Significance of PNP(Purine Nucleoside Phosphorylase)Activity of Lymphocyte in Patients with Breast Cancer / T.Takahashi et al. / p426~426
  • General Lecture 443. Endocrine Environment and Immunological Functions of Lymphocytes in the Patients with Breast Cancer / M.Akimoto et al. / p426~426
  • General Lecture 444. Immunological and Biochemical Parameters in the Development and Prognosis of Malignant Tumors in the Head and Neck (First Publication in a Series) / A.Nakamura et al. / p427~427
  • General Lecture 445. Experimental Study on Cytotoxic Lymphocytes Induced with IL2 for Adoptive Immunotherapy of Cancer Patients / Y.Sugiyama et al. / p427~427
  • General Lecture 446. Studies on Lymphocyte Subsets and Interleukin 2 Activity of Non-Hodgkin's Lymphoma / Y.Suzuki et al. / p427~427
  • General Lecture 447. Augmentation of Cytotoxicity of Tumor Infiltrating Lymphocyte(TIL)by IL2 / K.Gotoh et al. / p428~428
  • General Lecture 448. Impaired Production of Interleukin 2 after Surgery / S.Arinaga et al. / p428~428
  • General Lecture 449. Adoptive Immunotherapy(AIT)Using Cultured Tumor-bearer-lymphocytes Augmentation of Its Therapeutic Effect against MOPC 104E-bearing Mice / N.Kan et al. / p428~428
  • General Lecture 450. Analysis of Immune Response in Patients with Cancer and the Effect of Specific Active Immuno-therapy Using Glycoreleted Antigen Derived from Cancer Cell Membrane / K.Ietomi et al. / p429~429
  • General Lecture 451. Complete Regression of Mouse Hepatoma Transplanted after Partial Hepatectomy and Its Immunological Involvement / M.Ono et al. / p429~429
  • General Lecture 452. The Analysis of the Immune Response to Irradiated Tumors Using Winn Assay / T.Inomata et al. / p429~429
  • General Lecture 453. Effect of Thymus Grafts in Nude Mice Transplanted with Spontaneous Tumor Which Has High Tendency of Metastasis / M.Iwamoto et al. / p430~430
  • General Lecture 454. Antitumor Effects of the Anti-hCG Antibody on Choriocarcinoma / S.Tadera et al. / p430~430
  • General Lecture 455. Prevention of Cancer Cell Dissemination / M.Sunami et al. / p430~430
  • General Lecture 456. Effects of Adjuvant Immunochemotherapy for Advanced Gastric Cancer after Surgery / N.Takahashi et al. / p431~431
  • General Lecture 457. Nonspecific Immunotherapy with Immunomodulators in Gastric Cancer Patients with Surgery / H.Miwa et al. / p431~431
  • General Lecture 458. The Effects of PSK Administration on Immunosuppressive Serum Factor in the Patients with Gastric Cancer / T.Notsuka et al. / p431~431
  • General Lecture 459. Changes of Immunological Status of Postoperative Gastric Cancer Patients with Long Term Administration of PSK / S.Yoshida et al. / p432~432
  • General Lecture 460. Enhancement of Immunocompetence of Local Lymph Nodes by Local Infusion of PSK / T.Ageta et al. / p432~432
  • General Lecture 461. Evidence of Actual Existence of Cancer Immunotherapy:Effectiveness of Immunotherapy and Specific Killing Activity of Regional Lymph Node Lymphocytes / T.Asano et al. / p432~432
  • General Lecture 462. BCG and Interferon Immunotherapy of gladder Cancer / T.Suzuki et al. / p433~433
  • General Lecture 463. Intravesical Bacillus Calmette-Guerin for Treatment of Bladder Tumor / T.Uchida et al. / p433~433
  • General Lecture 464. The Statistical Analysis of Advanced Cancer Patients in Treatment with an Extract from Human Tubercle Bacilli (S.S.M.) -Report VI / K.Fujita et al. / p433~433
  • General Lecture 465. A Chemosensitivity Test by Clonogenic Assay / N.Hirabayashi et al. / p434~434
  • General Lecture 466. Sensitivity Test of Anticancer Agents Using Human Tumor Xenografts in Nude Mice with Special Reference to Correlation between Clinical Effects and Chemotherapy of Colon Cancer / M.Yamaguchi et al. / p434~434
  • General Lecture 467. Remarkable Effects of Nebulization Chemotherapy in a Case of Bronchial Carcinoma / S.Koyama et al. / p434~434
  • General Lecture 468. Evaluation of Intraperitoneal Drug Therapy for Advanced Gastric Cancer (Second Report) / K.Maruyama et al. / p435~435
  • General Lecture 469. A Case of an Unresectable Hepatoma Who Survives for 29 Months by the Treatment of Periodical Chemotherapy / Y.Tsuji et al. / p435~435
  • General Lecture 470. Experiences of Intra-portal Infusion Chemotherapy for Liver Cancer / H.Ono et al. / p435~435
  • General Lecture 471. Basic and Clinical Study on Adriamycin Ointment--Greater Effect Achieved by Adding Compounds Which Increase Percutaneous Permeability / C.Yanagawa et al. / p436~436
  • General Lecture 472. Fundamental Study.on the Combination Therapy of Cisplatin and Peplomycin--Change of Cell Cycle Progression / M.Fujii et al. / p436~436
  • General Lecture 473. Aggressive Treatments for Pulmonary Metastases of Hepatoblastoma:Effects of Cisplatin and Wedge Resection of Metastatic Tumors / E.Arima et al. / p436~436
  • General Lecture 474. Treatment of Advanced Gynecological Malignancies with Cisplatin / H.Taniguchi et al. / p437~437
  • General Lecture 475. Effect of Cis-platin Combined Chemotherapy Supported by IVH in a 2 Year-Old Girl with Endodermal Sinus Tumor(EST)in Coccygeal Region / S.Shibata et al. / p437~437
  • General Lecture 476. Chemotherapy of CDDP for Recurrent Hormone Resistant Prostate Cancer / T.Takahashi et al. / p437~437
  • General Lecture 477. Clinical Effect of 4'-O-Tetrahydropyranyl-Adriamycin(THP-ADM)on Gynecological Malignant Diseases / M.Suzuki et al. / p438~438
  • General Lecture 478. Results of Long-term Surgical Adjuvant Chemotherapy for Breast Cancer,Especially According to Dosage Schedules and Its Duration / M.Fujimoto et al. / p438~438
  • General Lecture 479. Combination Effects of Non-specific Immunomodulators and Human IgG-gound Melphalan (K18) / T.Mori et al. / p438~438
  • General Lecture 480. Synergistic Effect of K-18(Conjugate of Melphalan and Human γ-globulin)and Hyperthermia for Treatment of Lewis Lung Carcinoma in Mice / R.Tamada et al. / p439~439
  • General Lecture 481. Combination Effects of K18 with Radiation / H.Noguchi et al. / p439~439
  • General Lecture 482. Antitumor Effects of K18 on Experimental Tumors / Y.Nakagami et al. / p439~439
  • General Lecture 483. Local Pathological Changes in the Skin at the Injections Site of Cases Receiving the Hemolytic Streptcoccal Agent OK-432 / H.Hanaue et al. / p440~440
  • General Lecture 484. Immunotherapy on Rats with Carcinoma Induced by Oral ENNG Administration--Especially,Trial of Oral OK-432 Administration / S.Nakamura et al. / p440~440
  • General Lecture 485. Prognosis Evaluation by Immunological Parameters in Nonspecific Immunotherapy / H.Hanaue et al. / p440~440
  • General Lecture 486. Clinical Results of the Immunosurveillance Therapy against Hepatoma / I.Sato et al. / p441~441
  • General Lecture 487. Investigation Concerning Immunopotentiator(PSK)in Canter of Female Reproduc-tive Organs / S.Fujisawa et al. / p441~441
  • General Lecture 488. Effect of Various Interferons and Interleukin-2 on NK Activities and ADCC in vitro / T.Taguchi et al. / p441~441
  • General Lecture 489. Recovery from Bone Marrow Suppression Caused by Anticancer Agent Using OK-432 / T.Tsurumi et al. / p442~442
  • General Lecture 490. Case Reports on Successful Cure of Rectal Cancer by Excision--Prognosis of Cases of Cure by Conservative Treatments / C.Tani et al. / p442~442
  • General Lecture 491. Report on Combined Treatment of Immunotherapy and Chemotherapy(PSK,OK432,Cis-Platinum,Adriamycin)on Primary Ovarian Cancer / M.Saito / p442~442
  • General Lecture 492. Successful Preoperative Chemotherapy in Patients with Malignant Teratomas / T.Matsushita et al. / p443~443
  • General Lecture 493. Non-Hodgkin's Lymphoma of the Thyroid Gland with the Tracheal Hemorrhage Caused by the Arterial Rupture / T.Nishimura et al. / p443~443
  • General Lecture 494. Influence of Immunopotentiators on the Activation of 5-FU Derivatives / H.Nakazato et al. / p443~443
  • General Lecture 495. The Clinical and Pathological Study on the Therapy of Floor-of-mouth Carcinoma / K.Yuki et al. / p444~444
  • General Lecture 496. Clinical Study of Radiotherapy with HCFU for Recurrent Breast Cancer Radiation and HCFU Study Group for Breast Cancer / T.Okawa et al. / p444~444
  • General Lecture 497. High-dose Combination Chemotherapy Supported by Autologous Bone Marrow Transplantation in Advanced Breast Carcinoma / T.Tajima et al. / p444~444
  • General Lecture 498. Clinical Results of Hyperthermia Combined with Radiation for Locally Advanced Superficial Malignancy / S.Yanagawa et al. / p445~445
  • General Lecture 499. Two Cases of Prostatic Sarcoma Treated by AVI and Pelvic Exenteration / N.Ike et al. / p445~445
  • General Lecture 500. Enhancement of Cytotoxity of Adriamycin and Vincristine in Established Human Renal Tumor Cell Line (NT) and Primary Human Kidney Cell(PHK)by Verapamil / Y.Watanabe et al. / p445~445
  • General Lecture 501. Combination Chemotherapy of Nicardipine and Vindesine Sulfate Cis-Diammine Dichloroplatinum (II) for Patients with Advanced Esophageal Carcinoma / S.Akazawa et al. / p446~446
  • General Lecture 502. The Effective Combined Chemotherapy with Ca⁺⁺Channel Brocker for Three Metastatic Cases of Gynecological Malignant Tumors / Y.Onishi et al. / p446~446
  • General Lecture 503. Inhibition of Hepatic Micrometastasis for Prophylactic Cancer Treatment:Portal Dynamic Study of ¹⁴C-5FU MCT Emulsion and Its Solution by Internal Administration / K.Tazawa et al. / p446~446
  • General Lecture 504. Cancer Associated Cellular Proteins as an Index of the Efficacy of Antitumor Agents / T.Takahashi et al. / p447~447
  • General Lecture 505. Adjuvant Chemotherapy with H-MTX-CF rescue,VCR,ADM and CPM for Osteosar-coma / S.Wada et al. / p447~447
  • General Lecture 506. An Analysis of Pulmonary Metastatic Foci in the Clinical Course of Osteosarcoma / Y.Nishimoto et al. / p447~447
  • General Lecture 507. A Combination Chemotherapy with Vincristine Adriamycin Cyclophospharnide and DTIC(CYVADIC)for Adult Soft Part Sarcomas of Extremities / S.Matsumoto et al. / p448~448
  • General Lecture 508. Clinical Study of Combination Chemotherapy with 5-FU, Aclacinomycin and Pred-nisolon on Patients with Advanced Cancers / Y.Ohashi et al. / p448~448
  • General Lecture 509. An Alternating Combination Chemotherapy for Small Cell Lung Cancer(SCLC):Results of Patients with Extensive Disease(ED) / S.Ozawa et al. / p448~448
  • General Lecture 510. Adjuvant Chemotherapy for.Pediatric Malignant Brain Tumor / K.Kawai et al. / p449~449
  • General Lecture 511. Evaluation of Carmofur for Head and Neck Cancer / K.Hirokawa et al. / p449~449
  • General Lecture 512. VMBM (Vincristine, Methotrexate, Bleomycin, Mitomycin-C) Regimen in the Treat- ment of Head and Neck Cancer / N.Kohno et al. / p449~449
  • General Lecture 513. Low Dose Ara-C Treatment in Acute Non-lymphocytic Leukemia / N.Katayama et al. / p450~450
  • General Lecture 514. A Phase II-III Trial of Peplomycin in Malignant Lymphoma / K.Sampi et al. / p450~450
  • General Lecture 515. Decreased Pulmonary Toxicity of Peplomycin Infused Continuously and Sub-cutaneously with Microinfusion Pump / I.Satake et al. / p450~450
  • General Lecture 516. Administration of Mitornycin-C with an Inactivator / M.Takahashi et al. / p451~451
  • General Lecture 517. The Effect of Coenzyme Q10 on Side Effects of Adriamycin: Part 1 Marrow Depression,Liver Dysfunction and Alopetia etc. / A.Tateishi et al. / p451~451
  • General Lecture 518. The Effect of Coenzyme Q10 on Side Effects of Adriamycin. Part 2 -EKG Findings- / Y. Yoshida et al. / p451~451
  • General Lecture 519. Side Effects of Vinblastin(VBL)Vincristin(VCR)Adriamycin(ADM)in Enhanced Chemotherapy with Calcium Channel Blocer(CCB) / M. Hatae et al. / p452~452
  • General Lecture 520. Macroscopic Change of Primary Early Gastric Cancer after Long Term 5-FU Administration / M. Hiratsuka et al. / p452~452
  • General Lecture 521. The Effect of Preoperative Treatment with 5-Fluorouracil in Gastric and Colorectal Cancer / Y. Kawaura et al. / p452~452
  • General Lecture 522. Phase II Study of Protracted Infusion of 5FU against Advanced Gastric Cancer / S. Yoshida et al. / p453~453
  • General Lecture 523. A Sequential Chemotherapy Using Mitomycin C and Tegafur in the Treatment of Gastric Cancer after Gastrectomy II. Two Year Survival / Y. Uematsu et al. / p453~453
  • General Lecture 524. Randomized Study of Postoperative Long-term Adjuvant Chemotherapy with Futraful and Mitomycin C for Gastric Cancer
  • Second Study (A Fourth Report) / T. Taguchi et al. / p453~453
  • General Lecture 525. Adjuvant Chemotherapy to Curative Surgery in Gastric Cancer / T. Kimura et al. / p454~454
  • General Lecture 526. Clinical Evaluation of Postoperative Adjuvant Chemotherapy for the Gastric Cancer / K. Takeshita et al. / p454~454
  • General Lecture 527. AF Therapy for Recurrent Gastric Cancer / T. Yamada et al. / p454~454
  • General Lecture 528. A Combination Chemotherapy with ACNU or Adriamycin and 5-FU for End Stage Gastric Cancer / Y. Rai et al. / p455~455
  • General Lecture 529. Treatment of Advanced Gastrointestinal Cancer with Carmofur(1-Hexylcarbamoy1-5- FU
  • HCFU)and Mytomycin C(MMC)--A Report of Tohoku HCFU Study Group / A. Wakui et al. / p455~455
  • General Lecture 530. Sequential Methotrexate(MTX)/5-Fluorouracil(5FU)Therapy of Patients with Gastrointestinal Carcinoma / Y. Maeda et al. / p455~455
  • General Lecture 531. The Combination Chemotherapy of Sequential CPM-MTX-5FU for Recurrent and Advanced Cancer Patients / K. Yoshinaka et al. / p456~456
  • General Lecture 532. Mass Washing-off Therapy of Mitomycin C in the Peritoneal Cavity in the Surgery of Gastric Cancer and Effect on the 5 Year Survival Rate / H. Takahashi et al. / p456~456
  • General Lecture 533. Chemotherapy against Carcinomatous Peritonitis and Pleuritis Using Activated Carbon Particle Adsorbing Mitomycin C / A. Hagiwara et al. / p456~456
  • General Lecture 534. Effects of Mitomycin C-dextran Conjugate in the Treatment of Advanced Abdominal Cancers / K. Honda et al. / p457~457
  • General Lecture 535. Macroscopic Changes of Gastric Cancer by Cancer Chemotherapy / T. Izumi et al. / p457~457
  • General Lecture 536. Cancer Chemotherapy of Borrmann Type 4 Gastric Cancer--Analysis of the Questionnaire on the Effective Cases / M. Kurihara et al. / p457~457
  • General Lecture 537. Clinical Significance of Tissue Polipeptide Antigen in the Field of Obstetrics and Gynecology / I. Fukazawa et al. / p458~458
  • General Lecture 538. TPA, CEA, IAP and CA-125 in Patients with Gynecological Malignancies / A. Nakanishi et al. / p458~458
  • General Lecture 539. Study of Tissue Polypeptide Antigen(TPA)in Malignant Urological Patients / T. Arakawa et al. / p458~458
  • General Lecture 540. Clinical Evaluation of Urine and Serum TPA Levels in Urological Cancer / H. Tsujihashi et al. / p459~459
  • General Lecture 541. Serum Tissue Polypeptide Antigen(TPA)in Patients with Urogenital Cancer / M. Matsushima et al. / p459~459
  • General Lecture 542. Serum Tissue Polypeptide Antigen(TPA)Levels in Patients with Urologic Cancer / K. Yamazaki et al. / p459~459
  • General Lecture 543. Clinical Evaluation of Tumor Markers in Patients with Lung Cancer / Y. Matsubara et al. / p460~460
  • General Lecture 544. Application of Discriminant Analysis to Detect the Recurrence of the Breast Cancer / S. Shimizu et al. / p460~460
  • General Lecture 545. Clinical Evaluation of Serum Tissue Polypeptide Antigen (TPA) Measurement in Breast Cancer Patients / T. Shiga et al. / p460~460
  • General Lecture 546. Usefulness of Urinary Polyamine as a Cancer Marker in Digestive Organ Cancer / T. Suzuki et al. / p461~461
  • General Lecture 547. TPA, CEA and Polyamine in Breast Cancer / H. Suzuki et al. / p461~461
  • General Lecture 548. The Changes of Polyamine Levels in Erythrocytes, Plasma and Urine of Childhood Malignancies along the Course of Cancer Chemotherapy / M. Kubo et al. / p461~461
  • General Lecture 549. Not Received / /
  • General Lecture 550. Clinical Evaluation of Serum CAl25 Determination by Monoclonal Antibody as a Tumor Marker for the Malignant Ovarian Tumor / T. Arai et al. / p462~462
  • General Lecture 551. A Study of Serum Levels of CAl25 of Patients with Malignant Gynecologic Tumors / Y. Abe et al. / p462~462
  • General Lecture 552. Monitoring Human Gynecologic Malignancies Using CA-125 and CA19-9 Immuno-radiometric Assay Kits / T. Ogasawara et al. / p462~462
  • General Lecture 553. The Evaluation of Serum CA 125 in the Patients with the Various Gynecological Diseases / H. Iketani et al. / p463~463
  • General Lecture 554. Clinical Usefulness of Monoclonal Antibody,CA 125 and CA 19-9,in Ovarian Cancer / S. Saitoh et al. / p463~463
  • General Lecture 555. Clinical Evaluation of CA125 in Gynecologic Diseases / K. Ohmi et al. / p463~463
  • General Lecture 556. CAl25,a Circulatory Tumor Antigen of Epithelial Ovarian Cancer / K. Kuzuya et al. / p464~464
  • General Lecture 557. Clinical Significance of New Tumor Marker CA 125 in Gynecological Cancer / E. Kimura et al. / p464~464
  • General Lecture 558. Significance of Measurement of Several Tumor Markers and Mc-Ab CAl25 in Serum of Patients with Carcinoma of the Ovary / Y. Kikuchi et al. / p464~464
  • General Lecture 559. Detection of CAl25 in Sera from Patients with Gynecologic Neoplasma / H. Yabushita et al. / p465~465
  • General Lecture 560. Clinical Significance of Serum CA19-9 Determination in Patients with Digestive Cancers / R. Hamazoe et al. / p465~465
  • General Lecture 561. Study for Clinical Significance of Tumor-markers in Hepato-biliary and Pancreatic Diseases / N. Uehara et al. / p465~465
  • General Lecture 562. Diagnosis of Intrahepatic Cholangiocarcinoma Derived from Thorotrastosis Using Serum Tumor Marker,CA19-9 / Y. Ariyoshi et al. / p466~466
  • General Lecture 563. Clinical Studies on Factors Influencing Serum Levels of CA19-9 / Y. Takemori et al. / p466~466
  • General Lecture 564. Clinical Evaluation of CEA and CA 19-9 in Immunoperoxidase Assay in Pancreatic Cancer and Bile Duct Cancer / T. Uematsu et al. / p466~466
  • General Lecture 565. Correlation between Serun Levels and Immunohistochemical Distributions of CA19-9 in Colorectal Cancers--In Comparison with CEA / K. Okuda et al. / p467~467
  • General Lecture 566. Studies on the Treatment of the Pancreatic Cancer / K. Kato et al. / p467~467
  • General Lecture 567. Internal Drainage Operation for Carcinoma of the Pancreas and Biliary Tract / H. Miyata et al. / p467~467
  • General Lecture 568. Lymphnode Metastases and Prognosis after Surgery in Carcinoma of Head of the Pancreas and Periampullary Region / T. Sekoguchi et al. / p468~468
  • General Lecture 569. Clinicopathological Study on Large Cancers(Duct Cell Carcinoma)of Pancreas / J. Kamiya et al. / p468~468
  • General Lecture 570. Treatment of Intractable Ascites for Patients with a Terminal Gynecologic Malignant Tumor / K. Takahashi et al. / p468~468
  • General Lecture 571. Effect of Oral Administration of Morphine Hydrochloride on the Pain in Cases in the Terminal Stage of Cancer in the Digestive Organ / Y. Inoue et al. / p469~469
  • General Lecture 572. Preliminary Result of Field-testing in Japan of WHO(World Health Organization)Draft Interim Guideline on Relief of Cancer Pain / F. Takeda et al. / p469~469
  • General Lecture 573. Intracellular Uptake, Retention and Cytotoxic Effect of Adriarnycin(ADR)Combined with Hyperthermia in vitro / S. Nagaoka et al. / p469~469
  • General Lecture 574. Cytokinetic Studies on the Action of Hyperthermia for the KB-cells in vitro / K. Yokosuka et al. / p470~470
  • General Lecture 575. Anti-tumor Effect of Hyperthermia Plus Hematoporphyrin Derivative in Malignant Brain Tumor / H. Hondo et al. / p470~470
  • General Lecture 576. Hyperthermochemotherapy for Peritoneal Dissemination of Cancer by Peritoneal Perfusion with Cisplatin(CDDP)-Sodium Thiosulfate(STS)-"2-channel Method" / F. Tsukamoto et al. / p470~470
  • General Lecture 577. Fundamental Studies on Hyperthermochemotherapy / R. Shrestha et al. / p471~471
  • General Lecture 578. Treatment of Murine Ascites Tumor with Cis-DDP, Whole-Body Hyperthermia or Both Agents in Combination / K. Komatsu et al / p471~471
  • General Lecture 579. Computerized Processing of Temperature Data in Hyperthermia / T. Nakajima et al. / p471~471
  • General Lecture 580. Studies on Selective Embolo-hyperthermic Therapy of Tumors by Using Induction Heating and Ferromagnetic Embolization / M. Sako et al. / p472~472
  • General Lecture 581. Significance of Combined Angiotensin II(AGT II)Treatment in Total-body Hyperthermia(TBHT) / M. Maeta et al. / p472~472
  • General Lecture 582. Effects of Systemic Hyperthermia for Cancer Using Extracorporeal Circulation on Glycometabolism and Lipometabolism / K. Tsukada et al. / p472~472
  • General Lecture 583. Water Metabolism Disorder Induced by Combined Use of Cis-DDP and Whole-Body Hyperthermia in Mice / W. Nakamura et al. / p473~473
  • General Lecture 584. The Influence of Hyperthermia on Cerebral Functions / N. Yamada et al. / p473~473
  • General Lecture 585. Radiofrequency Hyperthermia for Malignant Brain Tumor--An Attempt of Clinical Use / N. Yamada et al. / p473~473
  • General Lecture 586. Combined Therapy of Radiofrequency Hyperthermia and Irradiation for Advanced Urological Cancers / H. Hisazumi et al. / p474~474
  • General Lecture 587. RF Thermotherapy for Locally Advanced Hepatocellular Carcinoma / M. Hiraoka et al. / p474~474
  • General Lecture 588. Hyperthermochemotherapy in the Treatment of Advanced and Recurrent Breast Cancer / T. Taguchi et al. / p474~474
  • General Lecture 589. RF Hyperthermia Combined with Radiotherapy in the Treatment of Advanced Abdominal and Pelvic Tumors / K. Akuta et al. / p475~475
  • General Lecture 590. Clinical Evaluation of Hyperthermia Combined with Radiotherapy / T. Matsuda et al. / p475~475
  • General Lecture 591. An Analysis of Hyperthermia Employing RF Heating Method / T. Matsuda et al. / p475~475
  • General Lecture 592. Thermometry Results of RF Capacitive Heating for Human Deep-seated Tumors / S. Jo et al. / p476~476
  • General Lecture 593. Clinical Trial of Radiofrequency Hyperthermia Treatment for Liver and Pancreas Malignancies / M. Miyazaki et al. / p476~476
  • General Lecture 594. Clinical Evaluation of Patients Responded to Systemic Hyperthermia (SHT) / N. Kato et al. / p476~476
  • General Lecture 595. Combined Hyperthermic Treatment--Whole Body,Radiofrequency and Microwave / H. Nagae et al. / p477~477
  • General Lecture 596. Experimental Studies on the Combined Modality of Bacillus Calmette-Guerin Treatment and Local Hyperthermia for Malignant Tumor (BCG) / T. Ichihashi et al. / p477~477
  • General Lecture 597. The Effect of the Continuous Hyperthermic Peritoneal Perfusion, Using a High Dose Cis-diamminedichloroplatinum for Peritoneal Dissemination of Gastric Cancers / Y. Yonemura et al. / p477~477
  • General Lecture 598. Radiotherapy with Hyperthermia by Radiofrequency for Bladder Cancer / K. Tashiro et al. / p478~478
  • General Lecture 599. Distant' Metastasis of Cancer of the Thyroid / Y. Matsurnura et al. / p478~478
  • General Lecture 600. Clinical Evaluation of Secondary Thyroid Cancer Simulating Primary Tumor / M. Hoshino et al. / p478~478
  • General Lecture 601. Bone Metastasis of Bladder Cancer--A Clinicopathological Study / H. Sekine et al. / p479~479
  • General Lecture 602. Inhibition of Hematogenous Metastasis by Indomethacin (Ind): Model Studies with Transplantable Murine Colon Adenocarcinoma 26 (C26) and Lewis Lung Carcinoma (3LL) / M. Niwa et al. / p479~479
  • General Lecture 603. Combination Effect of Prostaglandin I₂ (PGI₂) and Adriamycin (ADR) on Pulmonary Metastasis of Meth A Fibrosarcoma Cell / K. Kogawa et al. / p479~479
  • General Lecture 604. Distant Metastases in Head and Neck Cancer Patients / Y. Nakashima et al. / p480~480
  • General Lecture 605. An Isolated Huge Metastatic Node in Head and Neck Carcinoma / S. Makino et al. / p480~480
  • General Lecture 606. Clinical Study on Lymph Node Metastasis from Gastric Cancer / H. Isozaki et al. / p480~480
  • General Lecture 607. Lymphodynamics and Mode of Lymph Node Metastasis in Breast Cancer / Y. Saeki et al. / p481~481
  • General Lecture 608. Metastasis in the Supraclavicular Lymph Nodes after Radical Surgery for Breast Cancer / Y. Nishizawa et al. / p481~481
  • General Lecture 609. Histological and Endocrinological Studies of Primary Lesion and Metastatic Lymph Node in Prostatic Cancer / N. Kitajima et al. / p481~481
  • General Lecture 610. Lymph Node Involvement of Thoracic Esophageal Cancer / T. Kabuto et al. / p482~482
  • General Lecture 611. The Mode of Recurrence of the Esophageal Carcinoma after the Curative Surgical Treatment / H. Watanabe et al. / p482~482
  • General Lecture 612. The Significance of Pancreatectomy Combined with Splenectomy in Cancer of the Superior and Middle Gastric Regions with Special Reference to Lymph Node Metastasis / T. Arai et al. / p482~482
  • General Lecture 613. Evaluation of the Combined Resection of Pancreas and Spleen with Gastrectomy for the Purpose of Complete Removal of Lymph Nodes / S. Yamada et al. / p483~483
  • General Lecture 614. The Effect of Surgical Treatment for Gastric Cancers with Peritoneal Metastasis / Y. Yonemura et al. / p483~483
  • General Lecture 615. Surgical Treatment of Hematogenous Metastases from Colorectal Cancers / S. Takashima et al. / p483~483
  • General Lecture 616. Studies of the Sternomastoid Myocutaneous Flaps for Reconstructive Surgery of the Head and Neck / M. Okuda et al. / p484~484
  • General Lecture 617. Comparative Study of Five Methods of Pharyngoesophageal Reconstruction / S. Takeoda et al. / p484~484
  • General Lecture 618. Complication of Central Nerve System on Head and Neck Tumor and the Therapy / S. Akai et al. / p484~484
  • General Lecture 619. A Study on Relation between Spread of Metastases to Cervical Lymph Nodes and Prognosis in Cases with Oral Cancers--Especially in Those with Ipsilateral Metastases / T. Tachibana et al. / p485~485
  • General Lecture 620. Relation between Metastasis Time to Cervical Region and Therapeutic Results in Tongue Cancer / T. Amagasa et al. / p485~485
  • General Lecture 621. Studies on Patients Undergoing Total Thyroidectomy / I. Oka et al. / p485~485
  • General Lecture 622. Prognosis of 39 Cases of Renal Cell Carcinoma / H. Masuda et al. / p486~486
  • General Lecture 623. Clinical Study on stage IV Renal Cell Carcinoma / Y. Kitano et al. / p486~486
  • General Lecture 624. Clinical Aspect of Renal Cancer / H. Koike et al. / p486~486
  • General Lecture 625. A Clinical Survey on 102 Cases of Renal Pelvic and Ureteral Tumors / Y. Tada et al. / p487~487
  • General Lecture 626. Clinical Studies of the Renal Pelvic and Ureteral Cancer / M. Moriyama et al. / p487~487
  • General Lecture 627. Radical Operation for the Prostatic Carcinoma / S. Kumagai et al. / p487~487
  • General Lecture 628. Clinical Evaluation of Total Cystectomy on the Patients with Bladder Cancer / M. Nakano et al. / p488~488
  • General Lecture 629. "The Quality of Life" for Patients after Total Cystectomy with Ileal Conduit / M. Miyakawa et al. / p488~488
  • General Lecture 630. Transurethral Resection for Bladder Cancer / K. Fujita et al. / p488~488
  • General Lecture 631. Clinicopathological Study of Multiple Mucosal Biopsy for Bladder Cancer / K. Uchida et al. / p489~489
  • General Lecture 632. Relationship among Result of Multiple Mucosal Biopsy for Bladder Carcinoma, Treatment and Clinical Course / M. Igawa et al. / p489~489
  • General Lecture 633. Correlation between the Endoscopic Classification and Cell Surface Appearance by Scanning Electron Microscopy(SEM)in Urinary Bladder Tumor / K. Takai et al. / p489~489
  • General Lecture 634. Effect of Transcatheter Arterial Embolization upon Survival in Hepatocellular Carcinoma / H. Kanamori et al. / p490~490
  • General Lecture 635. Results of Tumor Enucleation for Small Liver Cancer / K. Takasaki et al. / p490~490
  • General Lecture 636. Studies on Primary Carcinoma of the Liver Survived More Than 3 Years after Surgery / Y. Yamazaki et al. / p490~490
  • General Lecture 637. Carcinoma of the Middle and Lower Biliary Tract--Type of the Cholangiogram and Microscopic Study / E. Shimozawa et al. / p491~491
  • General Lecture 638. Our Experience (8 Cases) of the Extrahepatic Choledochectomy for the Carcinoma of the Gallbladder / A. Usui et al. / p491~491
  • General Lecture 639. The Quantitative Correlation between Anemia and Hypoproteinemia of Cancer Patients / T. Sakoh et al. / p491~491
  • General Lecture 640. Consideration of Blood Transfusion to Patients with Malignant Tumor / T. Kamano et al. / p492~492
  • General Lecture 641. Nutritional Assessment and Influence of Total Parenteral Nutrition (TPN) for the Patients with Recurrent Cancer / K. Yoshioka et al. / p492~492
  • General Lecture 642. Basic Study of New Aminoacid Imbalance Solution--KKM-1 and KKM-2 / K. Omura et al. / p492~492
  • General Lecture 643. Change of the Serum Ch-E (Cholinesterase) Level Pre-and Posthepatectomy for the Liver Cancer--Especially in Connection with Infusion of ffp and Post Operative Complications / N. Mitsumori et al. / p493~493
  • General Lecture 644. Percutaneous Lymph Node Needle Biopsy / S. Hashimoto et al. / p493~493
  • General Lecture 645. Incidence of Aortic Node Metastasis in Epithelial Carcinoma of the Ovary / K. Matsukuma et al. / p493~493
  • General Lecture 646. Diagnostic Efficacy of Bile Cytology in Obstructive Jaundice / T. Sugita et al. / p494~494
  • General Lecture 647. The Preparation of Clinical Specimens for High Resolution Flow Cytometry Using Percoll Gradient / M. Ikeda et al. / p494~494
  • General Lecture 648. Flow Cytometric Investigation of Human Bladder Carcinoma
  • An Attempt to Clinical Application / T. Nasu et al. / p494~494
  • General Lecture 649. Evaluation of Urinary Cytology for Upper Urinary Tract Disease / T. Takeuchi et al. / p495~495
  • General Lecture 650. Study of Exfoliative Urinary Cytology / T. Tanahashi et al. / p495~495
  • General Lecture 651. Studies on Contact-Micro-Cystoscopy The Second Report:Clinical Use of Micro-Endoscope 27015B / M. Nakao et al. / p495~495
  • General Lecture 652. Percutaneous Fine Needle Aspiration Biopsy and Cytology of Renal and Retro-peritoneal Masses / K. Naito et al. / p496~496
  • General Lecture 653. Serum Gastrin Level in Patients with Colorectal Cancer / I. Fukuda et al. / p496~496
  • General Lecture 654. Diagnostic Values of Serum Concentration of the Type III Procollagen N-Terminal Peptide in Gastric Cancer / S. Akazawa et al. / p496~496
  • General Lecture 655. Subclinical Endotoxemia in Gastric Cancer Patients--Employing PNA Synthetic Stroma Endotoxin Measurement / H. Hanaue et al. / p497~497
  • General Lecture 656. Serum Prolactin and Estrogen Profiles in Postoperative Recurrent Breast Cancer / M. Endow et al. / p497~497
  • General Lecture 657. Detection of Fibronectin in Human Cartilaginous Tumors and Its Diagnostic Application / T. Yagi et al. / p497~497
  • General Lecture 658. Studies on Hemostatic Abnormalities of Patients with Hematopoietic Malignancy--The Analysis of Adult T-cell Leukemia / T. Ueno et al. / p498~498
  • General Lecture 659. Clinical Study of the Clonogenic Assay / T. Kubota et al. / p498~498
  • General Lecture 660. The Significance of Human Tumor Clonogenic Assay in Patients with Pleuritis Carcinomatosa / E. Shimizu et al. / p498~498
  • General Lecture 661. Investigation of Chemosensitivity in Gastrointestinal Tumor by Human Tumor Stem Cell Assay / M. Yamagata et al. / p499~499
  • General Lecture 662. Human Tumor Clonogenic Assay of Breast Cancer--Comparison with Different Source of Cells / S. Ishii et al. / p499~499
  • General Lecture 663. Human Tumor Stem Cell Assay for in vitro Chemosensitivity Test of Gynecologic Malignancies / T. Kano et al. / p499~499
  • General Lecture 664. Chemosensitivity Tests with the Human Tumor Stem Cell Assay for Urogenital Malignancies / T. Sakuramoto et al. / p500~500
  • General Lecture 665. The Correlation between Optical Density and Colony Forming in in vitro Sensitivity Test of TCFU / M. Usugane et al. / p500~500
  • General Lecture 666. Heterogeneity of Chemosensitivity Response of Human Tumors / N. Tanigawa et al. / p500~500
  • General Lecture 667. Establishment of New Ovarian Cancer Tumor Line in Nude Mice and Its Application to Treatment of the Donor Patient / M. Sawada et al. / p501~501
  • General Lecture 668. Gene Amplification and Effects of Chemotherapy: A Neuroblastoma Xenograft Study / Y. Tsuchida et al. / p501~501
  • General Lecture 669. Experimental Chemotherapy of Human Gastrointestinal and Breast Cancer Xenografts in Nude Mice and Its Correlation to Clinical Effects / M. Fujita et al. / p501~501
  • General Lecture 670. A New Sensitivity Test to CDDP Based on Flow Cytometric DNA Analysis / Y. Shinohara et al. / p502~502
  • General Lecture 671. Antitumor Effect of Cis-Platin Analogue (JM-8) on Testicular Tumor Line in Nude Mice and Clonogenic Assay / T. Hashimura et al. / p502~502
  • General Lecture 672. Sensitivity of Human Esophageal Cancer to Bleomycin and Cisplatin and Selection of Supplementary Chemotherapy Combined with Surgical Treatment / N. Matsumoto et al. / p502~502
  • General Lecture 673. Peplomycin Sensitivity of Various Kinds of Human Gynecological Cultured Tumor Cells / M. Ueda et al. / p503~503
  • General Lecture 674. In vitro Drug Sensitivity Test for Human Lung Cancer Cell Line (PC-7) Using ³H-thymidine and Human Tumor Clonogenic Assay / H. Nomori et al. / p503~503
  • General Lecture 675. Not Received / /
  • General Lecture 676. Not Received / /
  • General Lecture 677. Adjuvant Immunochemotherapies and Postoperative Survival Rates of Gastric Cancer Patients / J. Hosoi et al. / p503~503
  • General Lecture 678. Immunity in Pre-and Postoperative State and Prognosis of Breast Cancer Patients / T. Inamoto et al. / p504~504
  • General Lecture 679. Effects of Immunochemotherapy after Surgery for Breast Cancer in Terms of the Cummulative Survival Rate / T. Shimizu et al. / p504~504
  • General Lecture 680. Pathohistological and Immunological Research of Spontaneous Regression or Long Survival Cancer Cases (X) -The Analytical Study of the Lung Cancer(Small Cell Carcinoma)Patients- / S. Nakagawa et al. / p504~504
  • General Lecture 681. Studies on the Effect of Immunotherapy for the Patients with Advanced Cervical Cancer / K. Hasegawa et al. / p505~505
  • General Lecture 682. Immunotherapy of Gastric and Colo-rectal Cancers and Changes of Immune Status of the Patients / S. Matsumoto et al. / p505~505
  • General Lecture 683. Effects of Preoperative Intratumoral Injection of Immunopotentiator / A. Gochi et al. / p505~505
  • General Lecture 684. Effects of i.p. Administration of OK-432 against Patients of Peritonitis Carcinomatosa / K. Nakatani et al. / p506~506
  • General Lecture 685. Changes of T and NK Subsets after Local Injection of OK-432 into the Pleural Effusions and Tumors of the Advanced Cancer Patients / I. Kokunai et al. / p506~506
  • General Lecture 686. Intratumoral Administration of OK-432 in Thyroid Carcinoma and Head and Neck Cancer:Morphological Studies on Anti-tumor Effect Employing Immunocytochemical Tech-nique / A.Sugenoya et al. / p506~506
  • General Lecture 687. OK-432 in the Management of Head and Neck Cancer / K.Inoue et al. / p507~507
  • General Lecture 688. Review of Immunological Chemotherapy after Surgery for Gasttic Cancer--Changes in Killer Activity and humoral Antigen / T.Tabuchi et al. / p507~507
  • General Lecture 689. Immunological Behavior of Patients with Ovarian Cancer during Chemotherapy and Immunochemotherapy / J.Hamai et al. / p507~507
  • General Lecture 690. Selective Intraarterial Infusion of OK-432 to Advanced Malignancies / k.Sakamoto et al. / p508~508
  • General Lecture 691. Studies on Intratumoral Injection of OK-432 by Ultrasonically Guided Puncture for Hepatoma / H.Yasuda et al. / p508~508
  • General Lecture 692. Picibanil Therapy for Bladder Cancer / K.Fujita er al. / p508~508
  • General Lecture 693. The Antitumor Effects of Neutrophils Induced by a Streptococcal Preparation,OK-432 / K.Umemoto er al. / p509~509
  • General Lecture 694. Cytotoxic Activity of Lymphocytes in Carcinomatous Pleural Effusion and Its Augmentation by OK432 / T.Hori et al. / p509~509
  • General Lecture 695. Significance of Su-PS Skin Test for Immunoparameter in Treatment of Gasttic Cancer Patients / A.Ohtsuka et al. / p509~509
  • General Lecture 696. The Effects of Oral Administration of Streptococcal Preparation OK-432(Picibanil)on Mixed Lymphocyte Tumor Reaction and in vivo Anti-tumor Immunity of Mice with Transplanted Cecal Tumors / T.Tsuchitani et al. / p510~510
  • General Lecture 697. Post-operative Immunocompetence Following Surgical Stress in Gastric Cancer Patients and Effects of Pre-operative OK-432 Administration / S.Saji et al. / p510~510
  • General Lecture 698. Surgical Adjuvant Immunochemotherapy of Colorectal Cancer Using Intracutaneous Injection of OK-432 / T.Yamanaka et al. / p510~510
  • General Lecture 699. Influence of Preoperative Immunotherapy with Levamisole on Lymphocytes in Gastric Regional Node and Peripheral Blood--Determination of T-Cell Subsets Using Monoclonal Antibody / S.Owada et al. / p511~511
  • General Lecture 700.Randomized Controlled Trial of Postoperative Adjuvant Chemotherapy with Bestatin in Gastric Cancer / T.Tanaka et al. / p511~511
  • General Lecture 701. Immunotherapeutic Effect of Bestatin of Artificial Pulmonary Metastases in Murine Fibrosarcoma / K.Naito et al. / p511~511
  • General Lecture 702. Comparison of Enhancing Effects on Antitumor Immunity among Cyclophosphamide,Busulfan and Bleomycin / Y.Fujii et al. / p512~512
  • General Lecture 703. Increased Tumoricidal Effect on Liver Metastatic models Using Monoclonal Antibody Binding Liposomes as Drug Carriers / H.Suzuki et al. / p512~512
  • General Lecture 704. Clinical Studies on Plasma Exchange in Advanced Cancer patient(part VII) / A.Kameda et al. / p512~512
  • General Lecture 705. Attempt to Remove of Immunosuppressive Factors in the Serum of Cancer Patient--Regarding Simultaneous Use of DFPP and Adsorbent / M.Miyazaki et al. / p513~513
  • General Lecture 706. Evaluation of Plasmapheresis in Terminal Staged Patients with Urogenital Malignant Tumors / Y.Ogawa et al. / p513~513
  • General Lecture 707. Multiple Primary Neoplasms and the Mechanisms of These Consistence / Y.Bunden et al. / p513~513
  • General Lecture 708. Statistical Analysis of Multiple malignant Tumors of the head and Neck / H.Hosoda et al. / p514~514
  • General Lecture 709. Double Cancers among Patients with Gynecological Malignancies / H.Gomi et al. / p514~514
  • General Lecture 710. Second Malignancies of the Irradiated Area in Patients Treated for Uterine Cervix Cancer / T.Hamada et al. / p514~514
  • General Lecture 711. Endoscopic Nd-YAG Laser Therapy for Tumors of the Gastrointestinal Tract and Studies of the Contact Type of Quarts Fiber / S.Suzuki et al. / p515~515
  • General Lecture 712. Experimental Study of Photodynamic Therapy(PDT)Using Low Power Illumination / M.Yonekawa et al. / p515~515
  • General Lecture 713. Cytomorphological Changed Caused by HpD and Photodynamic Therapy / K.Nishimiya et al. / p515~515
  • General Lecture 714. The Experimental Study of Laser Photodynamic Therapy--The Evaluation of the Power Density of Laser Photodynamic Therapy on Culture Cells / H.Nanasawa et al. / p516~516
  • General Lecture 715. Interstitial Laser Irradiation for Bladder Cancer Using micro Laser Rod / H.Washida et al. / p516~516
  • General Lecture 716. Enhancement of Anti-tumor Effect of Anti-cancer Drug by Ultrasound / R.Akimoto et al. / p516~516
  • General Lecture 717. Fluctuation of Lymphocyte Subsets before and after Surgical Operation Using Flow-cytometry System / M.Kawahito et al. / p517~517
  • General Lecture 718. Analysis of T Cell Subsets with Monoclonal Antibody in the Patients with Digestive Cancer / M.Sato et al. / p517~517
  • General Lecture 719. The Usefulness of Carbohydrate Antigen 19-9(CA 19-9)for Detection of Primary Liver Cancer / H.Sano et al. / p517~517
  • General Lecture 720. A Case of Successfully Operated Metastatic Adrenal Carcinoma with High CEA Level in Post-operative Breast Cancer / M.Tokunaga et al. / p518~518
  • General Lecture 721. The Problems with the Measurement of Low Level hCG for the Management of Gestational Trophoblastic Disease / Y.Nishikawa et al. / p518~518
  • General Lecture 722. Pregnancy-specific β₁-glycoptotein(SP1)in Trophoblastic Disease / M.Ito et al. / p518~518
  • General Lecture 723. Multivariate Analysis of the Prognosis Uterine Cervix Cancer with Radiotherapy Using Serum CEA and Ferritin Values / S.Nishino et al. / p519~519
  • General Lecture 724. Clinical Evaluation of γ-Seminoprotein(γ-Sm)in the Patients with Prostate Cancer(1)Studies of Detective Method and Normal Serum Value / M.Kuriyama et al. / p519~519
  • General Lecture 725. Perforative Carcinoma of Colon and Rectum / K.Matsumura et al. / p519~519
  • General Lecture 726. Acute Abdomen Due to Malignant Neoplasm--Perforation in Alimentary Canal / A.Yamaguchi et al. / p520~520
  • General Lecture 727. Bone Marrow Necrosis / Y.Takahashi et al. / p520~520
  • General Lecture 728. The Treatment of Multiple Cerebral Infarction and Systemic Thrombophlebitis Due to Disseminated Intravascular Coagulation(DIC)in Ovarian Cancer / E.Soh et al. / p520~520
  • General Lecture 729. Hemostatic Treatment of Disseminated Intravascular Coagulation with Malignancy / M.Kuto et al. / p521~521
  • General Lecture 730. Cases with Asymptomatic Metastatic Brain Tumor Documented by CT Scan / Y.Kodama et al. / p521~521
  • General Lecture 731. T₃ Producing Thyroid Adenocatcinoma with Profound Bone Metastases / N.Aoki et al. / p521~521
  • General Lecture 732. A Case of Bilateral Metastatic Breast Cancer Originated from the Stomach / Y.Kasuga et al. / p522~522
  • General Lecture 733. The Study of the Gastric Cancer Associated with Pregnancy / Y.Satoh et al. / p522~522
  • General Lecture 734. Three Cases of Endometrial Carcinoma Occurring in Young Females during Therapy for Anovulation / T.Sekine et al. / p522~522
  • General Lecture 735. Villous Adenoma in the Large Bowel Following Ureterosigmoidostomy / T.Umeyama et al. / p523~523

「国立国会図書館デジタルコレクション(雑誌)」より

この本の情報

書名 日本癌治療学会誌 = The journal of Japan Society of Clinical Oncology
著作者等 日本癌治療学会
書名ヨミ ニホン ガン チリョウ ガッカイシ = The journal of Japan Society of Clinical Oncology
書名別名 The journal of Japan Society for Cancer Therapy

日本癌治療学会学術集会educational book

日本癌治療学会学術集会プログラム号

日本癌治療学会学術集会抄録号

The journal of Japan Society of Clinical Oncology

Nihon gan chiryo gakkaishi
巻冊次 20(2)
出版元 日本癌治療学会
刊行年月 1985-03
ページ数
大きさ 25-30cm
ISSN 00214671
NCID AN00187361
※クリックでCiNii Booksを表示
全国書誌番号
00018418
※クリックで国立国会図書館サーチを表示
言語 英語
日本語
出版国 日本
この本を: 
このエントリーをはてなブックマークに追加

Yahoo!ブックマークに登録
この記事をクリップ!
Clip to Evernote
このページを印刷

外部サイトで検索

この本と繋がる本を検索

ウィキペディアから連想